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Abstract 
The highly conserved terminal fourteen C-terminal residues of troponin T play a 
novel role in the regulation of striated muscle contraction. Elimination of the terminal 
fourteen residues of the C-terminal region of troponin T stabilizes the functional active 
state and destabilizes one of two inactive states, the blocked state. We’ve used a series 
of functional assays to assess the magnitude of disruption to the actin state distribution 
by different mutations within that C-terminus. In doing so, we have identified the 
characteristics of the C-terminus required for its function. To probe the structural 
mechanism of the C-terminus of troponin T, we used a series of FRET pairs to measure 
the interactions of the C-terminus of troponin T and how those interactions are disrupted 
by C-terminal mutation. 
Though mutation in the C-terminus of troponin T is associated with a specific 
cardiovascular disease, hypertrophic cardiomyopathy, the findings from our lab indicate 
this region’s function has broader implications on our fundamental understanding of 
striated muscle regulation and treatment of cardiovascular disease. Our incomplete 
understanding of this cycle’s regulation has led to the generation of a variety of 
hypothesis to explain the gaps in our knowledge. We have taken steps to characterize 
the functional and structural consequence of mutation within the C-terminus of troponin 
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Chapter 1: Background 
Introduction 
This dissertation was developed on the premise that the highly conserved 
terminal fourteen C-terminal residues of troponin T (C-terminus) play a novel role in the 
regulation of striated muscle contraction. In this Chapter, I will begin with a brief 
introduction to cardiovascular disease with a focus on clarifying the broader implications 
of our work. Although mutation in C-terminus of troponin T is associated with a specific 
cardiovascular disease, hypertrophic cardiomyopathy, the findings from our lab indicate 
this region has functions with broader implications to striated muscle regulation and 
treatment of cardiovascular disease. To realize the significance of this region, it is 
important to first understand the steps involved in the contractile cycle of myosin-actin 
interactions required to hydrolyze ATP and produce force. I will detail that cycle 
including the regulated steps and the proteins involved. Our incomplete understanding 
of this cycle has led to the generation of a variety of hypothesis to explain the gaps in 
our knowledge. The data presented in chapters three and four of this dissertation 
demonstrate steps we have taken to characterize the functional and structural 
consequence of mutation in the C-terminus of troponin T. I will discuss in Chapter 5 the 
significance of our findings and how we believe we have closed some of the gaps in our 




The broader implications of the genetic basis of Cardiomyopathy 
Cardiovascular disease (CVD) has a prevalence of 48% in the global population with 
over 121.5 million affected in the United States alone for men and women over twenty 
years of age 1. In 2016, over 840,000 deaths were attributed to cardiovascular disease 
in the United States and over 300,000 of those occurring suddenly or unexpectedly 2. 
Coronary artery disease (CAD) accounts for 80% of sudden cardiac deaths while the 
other 20% is composed of cardiomyopathies and other cardiac disorders1. Genes 
associated with disease have been identified for approximately 50-75% of hypertrophic 
cardiomyopathy cases and up to 40% of dilated cardiomyopathy cases1. Although there 
are extensive circumstantial risk factors and family history links with CAD 1, there is 
limited genetic evidence compared to that of heart diseases such as hypertrophic 
cardiomyopathy. The genetic, epigenetic, shared behavioral and shared environmental 
risk factors exemplify the complexity of this disease and make evident the difficulty in 
identifying the root cause2. 
Watkins et al.3 showed that familial hypertrophic cardiomyopathy was linked to 
mutations in the actin regulatory component troponin T. Since then, hypertrophic 
cardiomyopathy has become well established as a disease of the sarcomere4 as 
mutations in over ten proteins and over thirty mutations within troponin T alone have 
been linked to hypertrophic cardiomyopathy 5. Approximately 1 in 500 individuals have 
left ventricular hypertrophy, of whom 20% to 30% are likely to have a sarcomere 
mutation that suggests clinically expressed hypertrophic cardiomyopathy 1. Additionally, 
over ten mutations in troponin T have been linked to dilated cardiomyopathies 5. 
Hypertrophic cardiomyopathy is characterized by decreased left ventricle volume 
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resulting from thickening of the ventricle wall. Dilated cardiomyopathies on the other 
hand is characterized by increased left ventricle volume resulting from dilating of the left 
ventricle wall. It is interesting that hypertrophic cardiomyopathy and dilated 
cardiomyopathy can each arise from mutation within a single protein, troponin T, but 
have seemingly disparate phenotypes6. The molecular mechanism of this dual function 
of troponin T will play a central role throughout this dissertation.  
Targeting upstream signaling pathways was a goal of early cardiovascular disease 
treatments7. Those treatments often had wide ranging downstream effects targeting the 
sarcomere as well as ion channels and smooth muscle. The broad downstream effects 
of these upstream targets can further increase the chance of arrhythmias and 
hypotension already commonly present in those with CVD7. Targeting proteins of the 
sarcomere directly would permit safer and more personalized treatment by limiting the 
pathways affected. In addition to the restoration of compromised sarcomere function in 
familial myopathies, sarcomere modulation via targeting of sarcomeric proteins may 
have therapeutic value in a broader range of diseases that affect muscle function7. 
Clinical trials for the treatment of spinal muscular atrophy and amyotrophic lateral 
sclerosis using sarcomeric modulators for instance have already begun8. 
To modify sarcomeric function, it is essential to understand how the proteins making 
up the sarcomere interact. These proteins, including actin, myosin, tropomyosin and 
troponin, interact to convert hydrolysis of ATP into a conformational change that 
produces force.  
The energy of ATP is converted into a force producing conformational change where 
myosin and actin slide past one another. ATP is hydrolyzed by myosin alone at a 
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relatively low rate. Interaction of myosin with actin can accelerate this myosin ATPase 
(ATP hydrolysis) rate by several hundred-fold. The ability of actin to accelerate the 
ATPase activity is controlled by different mechanisms in different muscle types. 
Regulation by striated (skeletal and cardiac) muscle occur primarily through the 
regulatory proteins tropomyosin and troponin although a super relaxed state has 
recently been observed resulting from a change in myosin head structure9. Regulation 
of this ATPase activity in striated muscle is discussed below. 
Actin stimulates myosin ATPase Activity 
Myosin hydrolyzes ATP (Myosin ATPase activity) at a relatively low rate through 
the reaction scheme steps 1’, 3’ and 5’ shown in Figure 1. When crossbridges form 
between actin and myosin to form actomyosin, hydrolysis of ATP occurs more rapidly10. 
The steps in this acceleration of ATP hydrolysis rate by actin follows the reaction 
scheme (Figure 1) steps 1, 2, 3’,4, 5, 6, 7, and 8. 
 
 
Figure 1: Myosin ATPase Crossbridge Cycle. (-) indicates a weakly bound collision 
complex. (*) indicates interaction. (“) indicates a strongly bound state. Adapted From 11. 
 
Step 1 and step 1’ of the reaction scheme refers to the formation of a collision 
complex of ATP with actin-myosin and myosin respectively. Myosin-ATP rapidly 
dissociates from actin (step 2 of Figure 1) as ATP decreases the affinity of myosin for 
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actin. Actomyosin hydrolysis of ATP can be observed at low ionic strengths although it 
is significantly slower than cleavage by myosin alone and has a Keq of less than one12.  
Myosin retains the ATP hydrolysis products, ADP and Pi. This is thought to be 
the rate limiting step in the absence of productive interaction with actin (step 5’ of Figure 
1). Myosin*ADP*Pi forms a collision complex with actin (step 4 of Figure 1) which then 
isomerizes via step 5 of Figure 1 to form a more stable complex. Eisenberg 13 proposed 
a model where there is a slow ATPase rate limiting isomerization of myosin before 
formation of the myosin-ATP collision complex.  
 Following formation of this more stable complex in step 5, fibers studies 14,15 
suggest that myosin undergoes the force producing step (step 6 of Figure 1) 
responsible for myosin and actin sliding past one another. During or following this step, 
myosin releases its bound Pi which is thought to be the rate limiting step (step 7 of 
Figure 1). Steps 6 and 7 are believed to occur in sequence as evidenced by inducing a 
reversal of the crossbridge cycle via photogeneration of orthophosphate in rabbits 
psoas fibers and monitoring changes in isometric tension 14–16. It has also been 
suggested that steps 6 and 7 or even steps 5-7 occur simultaneously 17–19. Regardless, 
it is known that either step 5, 6 or 7 or a combination of them are responsible for the 
force producing conformational change based on the change in free energy between 
those states 20,21. Following these steps, actomyosin undergoes an isomerization 
followed by a rapid release of ADP (step 8 of Figure 1) 22,23. This isomerization step 
could also be the ATPase rate limiting step 24.  
 Formation of the closely associated complex (step 5 of Figure 1) and the rate 
limiting step (either step 6 or 7 of Figure 1) are thought to be controlled by calcium and 
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the troponin complex11,25,26. The different models developed to explain how calcium 
regulates the actin-myosin interaction via troponin are described below. 
Calcium regulates actin-myosin interaction via troponin 
Productive interaction of myosin with actin in striated muscle is dictated by the 
conformation of troponin and tropomyosin on actin. The conformation of troponin and 
tropomyosin on actin is dependent on the calcium concentration. Several models have 
been hypothesized to explain how calcium binding affects the conformation of troponin 
and tropomyosin.  
The classical steric blocking model describes regulation of the myosin ATPase 
with only a blocked and an open state of actin (Figure 2A). The blocked state is 
stabilized by the absence of calcium whereas the open state is stabilized by the 
presence of calcium. Note that ‘low calcium’ refers to the virtual absence of calcium, or 
less than 10-7 M (0.1 µM). ‘High calcium’ or ‘saturating calcium’ refers to a concentration 
of greater than 10-5 M (10 µM). In this model, the proportion of myosin bound directly 
correlates with the ATPase rate.  
It was observed that myosin S1 can bind actin even at low calcium 
concentrations and that non-activating species of myosin S1 (such as myosin-ADP) 
could cooperatively increase subsequent binding27,28. Although the apparent binding 
constant of myosin S1 is unaffected by calcium, the Vmax of the ATPase rate at low 
calcium concentrations is decreased to about 4% of that at saturating calcium 
concentrations. These observations suggested that a kinetic step in the hydrolysis or 
release of ATP was inhibited rather than the binding of myosin S1 to actin. New models 
were adapted to support this evidence where calcium and myosin function as allosteric 
7 
 
effectors of tropomyosin position rather than tropomyosin sterically blocking myosin 
binding28,29. 
The Hill model29 (Figure 2B) consists of three states of actin in which myosin-
ATP can bind to any of the states: 10, 12, or 2n. In the Hill model, the 10 state is at very low 
calcium concentrations and the 12 state is stabilized by saturating calcium but does not 
have maximal ATPase activity. The 2n state is stabilized by binding of activating forms 
of myosin S1 and exhibits maximal ATPase activity regardless of calcium concentration. 
Equilibrium titrations and kinetics of binding of myosin S1 revealed a discrepancy 
between the predicted distribution between the 10 and 12 states.  
A model proposed by McKillop and Geeves30 introduced a blocked state to the 
Hill model to reconcile that apparent discrepancy. The model proposed by Geeves30 
differs from the Hill model in three ways. That model states: 1) Myosin cannot bind to 
the blocked state 2) Myosin binds the closed and open states at an equal rate 3) The 
states are sequential in that actin passes through the closed state when switching 
between the blocked and open states. 
Though the Hill and Geeves models fundamentally differ in explaining the 
mechanism of troponin-tropomyosin regulating actin-myosin interaction, the results of 
our experiments presented here are not dependent on these models. The notations can 
be interchanged where the blocked state is analogous to 10, the closed state is 12, and 






Figure 2: Schematic of regulation as described by each model. Adapted from 31 A) 
Classical steric blocking Model B) Hill Model C) Geeves Model 
 
Step 4 or step 5 of the reaction scheme in Figure 1 is regulated by calcium via 
troponin and is the step where troponin is thought to induce tropomyosin movement. 
Understanding the structure of the regulatory complex and how subunits interact is 
important to understanding how mutations affect interactions. The structure of the 
regulatory complex and some of the known interactions of the troponin subunits are 
described below. 
X-ray crystallography, electron microscopy, fluorescence resonance energy 
transfer (FRET), and atomic modeling have been used to identify three structural states 
of troponin-tropomyosin on actin 32–38. Movement of tropomyosin between three distinct 
positions is well accepted although the specific conformation and interactions of those 
three positions is not well defined. Tropomyosin’s long helical repeating nature allows its 
position to be measured and mapped onto actin more readily than troponin. Several 
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groups have used known crystal structures, interatomic distances, and molecular 
modeling to virtually place troponin on reconstructed thin filaments to predict the 
conformation of troponin in each of the structural states35,36,39.  
Though there are three structural states of troponin-tropomyosin on actin thought 
to correspond to the three functional states, the blocked and closed states (using the 
Geeves notation) were considered functionally redundant in that they do not stimulate 
myosin ATPase activity. However, disrupting the distribution between the blocked and 
closed states can lead to cardiovascular disease40,41. Though each state is redundant in 
that they do not stimulate ATPase activity, they are not redundant based on the rate and 
equilibrium of myosin S1 binding.  
The distribution between the blocked and closed states must be considered in 
addition to the open state distribution. To understand regulation of actin by troponin and 
tropomyosin, these functionally unique states must be defined as diseases may result 
from changes in the distribution between each of the three functional states. Our work 
herein identifies some of the functional and structural differences between these three 
states. 
We know that there are three distinct structural states of actin-tropomyosin-
troponin though the position of troponin in each state is less clear. The unique rate of 
binding, equilibrium of binding, and ATPase stimulation of myosin in each of the three 
states must be the result of these differences in structure. The known structure and 
interactions among actin-tropomyosin-troponin have been thoroughly defined 




Interactions among actin-tropomyosin-troponin 
 One tropomyosin dimer extends across seven actin monomers (G-actin) in 
polymeric actin (F-actin) and the overlaps with an adjacent tropomyosin. One troponin 
complex binds near each tropomyosin overlap region. Actin contains four subdomains 
(Figure 3). Subdomains 1 and 2 are periphery and are exposed to solvent and myosin 
binding. Subdomains 3 and 4 are axial and interact with subdomains 3 and 4 of an 
adjacent actins strand. Alanine residues within tropomyosin force the tropomyosin dimer 
into a coiled coil that conforms to a long pitch helix on the surface of F-actin. Each 
tropomyosin monomer contains seven pseudo-repeats with highly negatively charged 
regions. These pseudo-repeats correspond with the seven actin monomers that each 
tropomyosin spans. The negatively charged regions of each pseudo-repeat interact with 
a positively charged region within the long pitch helix of actin. The electrostatic 
interactions between actin-tropomyosin in the long pitch helix are primarily the result of 
positively charged amino acids on subdomains 1 and 3 of actin. There is a larger 





Figure 3: Space filling models from electron micrographs a) actin showing subdomains 
1-4. b) actin with tropomyosin position overlayed. c) tropomyosin coiled coil 44,45 
 
As stated previously, evidence from X-ray crystallography, electron microscopy, 
FRET, and molecular modeling revealed movement of tropomyosin relative to actin 32–
38. This movement was described as an azimuthal shift of tropomyosin among three 
locations that differed primarily in their distance from the actin long pitch helix axis. 
These positions are illustrated in Figure 4. Electron microscopy data showed that 
addition of calcium resulted in a 25° shift of tropomyosin into the long pitch helix from its 
low calcium position 46. Addition of myosin resulted in an additional 10° shift into the 





Figure 4: Ribbon Diagram computationally generated from EM data showing actin with 
tropomyosin in different positions depending on conditions. Red, EGTA; Yellow, 
Calcium; Green, Rigor (No ATP) 36 
 
The movement of tropomyosin among those three states is determined by 
calcium binding to troponin and myosin binding to actin. The troponin complex is 
composed of troponin C (TnC), troponin I (TnI), and troponin T (TnT) which cooperate to 
respond to calcium and reposition tropomyosin along actin (Figure 5). This project is 
primarily concerned with a specific region of troponin, the C-terminus of troponin T, and 
how it is involved with this process. Functional evidence from our lab suggests this 
region plays a role in both the normal 25° azimuthal shift of tropomyosin but also in the 
additional 10° shift usually only achieved with binding of myosin47. A high resolution 
structure of the thin filament48 showed that tropomyosin is further from troponin at 
saturating calcium concentrations. The following text details the interactions of each 
troponin subunit with a focus on the interactions that may be involved with the C-




Figure 5: Diagram illustrating the position of tropomyosin and the subunits of 
troponin along actin 49 
 
Troponin I: The human cardiac isoform of the troponin subunit troponin I is made up of 
210 amino acids and consists of an acidic N-terminal domain (2-32), a structural IT-arm 
(residues 32-136), inhibitory domain (or inhibitory region) (residues 137-148), regulatory 
domain (or regulatory region) (149-160) and a C-terminal domain (163-210)( 
Figure 6)50.  
Residues 44-80 and 91-136 makeup the H1 and H2 alpha helices respectively. 
Residues 67-80 of the H1 alpha helix interact with the H2 alpha helix of troponin T51. 
The H2 alpha helix of troponin I interacts with the H2 alpha helix of troponin T (residues 
227-272) to form the IT-Helix. This point will be emphasized again, but it is important to 
note here that the IT helix is immediately adjacent to the C-terminal region of troponin T 
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which this project focuses on. The inhibitory region of troponin I extends from the C-
terminal end of the IT-Helix and is composed of residues 138-149 52 (or 130-14953). This 
is a very well characterized region that plays a critical role in calcium regulation and in 
this project. At very low calcium concentrations, the inhibitory region of troponin I 
interacts with a negatively charged region on actin54 via electrostatic interaction due to 
its highly positive charge (greater than 50% basic amino acids). This interaction 
stabilizes tropomyosin in a position that inhibits actin stimulation of myosin ATPase 
activity.  
The affinity of troponin I for troponin C is enhanced as calcium concentration is 
increased55. Little secondary structure was shown for the troponin I inhibitory region 
residues 138-148 at low calcium concentrations42,56. At higher calcium concentrations, 
residues 136-141 on troponin I form an alpha helix, dissociate from actin and interact 
with the N-terminal lobe of troponin C 53. Residues 142-149 of troponin I do not exhibit a 
secondary structure at either very low or saturating calcium52.  
Adjacent to the inhibitory region, residues 151-160 of troponin I make up the H3 
alpha helix (or regulatory domain or switch region) of troponin I 42. At saturating calcium 
concentration, the H3 alpha helix interacts with a hydrophobic cleft that opens on the N-
lobe of troponin C 57. Movement of troponin I into the hydrophobic cleft results in 
dissociation of the inhibitory region of troponin I from actin and release of the mobile 
domain (residues 163-210) of troponin I from actin and tropomyosin51,57. The inhibitory 





Figure 6: Schematic of Troponin I showing locations of interactions (A) and important 
regions (B). The inhibitory domain (ID), regulatory domain (RD) and mobile domain are 
calcium sensitive. 
 
Troponin C: The human cardiac isoform of the troponin subunit troponin C is 
composed of 161 amino acids 58. Troponin C is primarily divided into two globular 
regions, an N-lobe (residues 1-87) and a C-lobe (residues 92-161). A pair of EF hand 
domains is present in both the N-lobe and C-lobe of troponin C (Figure 7). In the N-lobe 
of the cardiac isoform of troponin C, EF-hand 1 is defunct and does not bind metal. EF-
Hand 2 in the N-lobe of troponin C is the regulatory, low-affinity, calcium binding region 
that upon binding calcium leads to a cascade of changes within troponin.  
 EF-hands 3 and 4 in the C-lobe of troponin C are high affinity and low divalent 
metal ion specificity. These sites are nearly always filled with either magnesium or 
calcium at physiological conditions59. The C lobe of troponin C interacts with the C-
terminal of the IT coiled coil42. Though the C-lobe of troponin C does not participate in 
calcium regulation, the documented interactions of the C-lobe of troponin C with 
troponin T and troponin I suggests that metal (calcium or magnesium) binding to the EF-
Hands in this lobe maintain these interactions. The C lobe of troponin C is therefore 






Figure 7: Schematic of Troponin C showing locations of interactions (A) and important 
regions (B) 43 
 
Binding of calcium to the regulatory EF-Hand in the N-lobe of troponin C opens a 
hydrophobic pocket. The H3 helix of troponin I (residues 150-159) known as the 
regulatory domain (or regulatory region or switch region) binds to that hydrophobic 
pocket in the N-lobe of troponin C upon opening (Figure 8)60. Binding of the regulatory 
region of troponin I to the troponin C hydrophobic pocket is associated with dissociation 
of the troponin I inhibitory region and mobile domain from actin and actin-tropomyosin 
respectively.  
Other troponin C binding sites are thought to be made available by the calcium 
induced conformational changes. These new sites are thought to present alternative 
binding sites for the inhibitory region (residues 137-148) and mobile domain (residues 
169-210) of troponin I for actin-tropomyosin42. These sites would reduce the affinity of 
troponin-actin interactions and result in interactions that position tropomyosin in a more 
activating position. The entire mechanism linking calcium binding to repositioning of 




Figure 8: Schematic diagram of the core domain of troponin illustrating subunit domains 
and possible responses to calcium42.TnT (yellow), TnI (blue/light blue), TnC (red), 
tropomyosin (orange), actin (green). 
 
Troponin T: The most common human cardiac isoform of the troponin subunit 
troponin T is made up of 288 amino acids. The four cardiac isoforms cTnT1-cTnT4 are 
produced by alternative splicing at exons 4 and 5 61,62 and are thought to alter thin 
filament calcium response. Troponin T contains an extended N-terminal region 
(TnT1,residues 2-68) that extends about half the length of tropomyosin 63 and a globular 
region (TnT2, residues 69-288) ( 
Figure 9).  
The globular region consists of a conserved region (residues 69-200) and C-
terminal region (residues 201-288). The conserved and C-terminal regions are 
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connected by a flexible linker made up of residues 183-200. Troponin T has two main 
interaction sites with tropomyosin known as T1 and T2.  
The T1 region of troponin T (residues 98-136) is well defined and interacts with 
the tropomyosin overlap region in a calcium independent manner 43. Evidence suggests 
that an alpha-helical region of troponin T interacts with tropomyosin to form a triple 
stranded coiled-coil with one-third of the length of the tropomyosin C-terminus64. 
Residues 204-220 of the C-terminal domain of troponin T make up the H1 alpha helix 
and residues 227-272 make up the H2 alpha helix42. troponin T residues 257-271 of the 
H2 alpha helix interact with the calcium binding loops within the troponin C C-terminal 
domain42.  
The H2 alpha helix of troponin T forms a coiled coil with the H2 alpha helix of 
troponin I 65 to form the IT-Helix. The last sixteen residues of the C-terminal region of 
troponin T (residues 273-288) are immediately adjacent to the IT-Helix. The function 
and structure of these last 16 residues are the central focus of this project. To avoid 
ambiguity, the last 16 residues of the C-terminal region of troponin T will be referred to 
as the C-terminus of troponin T.  
Unfortunately, the structure of the C-terminus of troponin T has not been 
resolved in crystal structures of troponin. This lack of resolution indicates that the C-
terminus is either a flexible, unstructured region or that it binds to actin or tropomysoin42. 
The crystal structures are limited in that they are of troponin alone in the absence of 
actin or tropomyosin.  
The C-terminus of troponin T can be phosphorylated by RhoA associated protein 
kinase II on residues 275 and 284 or by protein kinase C on residue 28466,67. However, 
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analysis of affinity purified troponin T from human tissue by mass spectroscopy has 
shown that only serine 2 is phosphorylated physiologically68. This brings into question 
the physiological relevance of phosphorylation to the C-terminus of troponin T. 
 
 
Figure 9: Schematic of Troponin T showing locations of interactions (A) and important 
regions (B) 43 
 
A focus of our work investigating the function and interactions of the C-terminus 
of troponin T is the spatial and sequence similarity of the C-terminus of troponin T with 
the well characterized inhibitory region of troponin I. Figure 10 shows an alignment of 
the C-terminus sequence with the inhibitory region of troponin T as they emerge from 
the IT-Helix. Both regions are highly positively charged. The C-terminal 16 residues of 
troponin T contains 7 basic residues (arginine or lysine) while the 12 residues of the 
troponin I inhibitory region contains 6 basic residues.  
 The hypertrophic cardiomyopathy associated mutation R278C of troponin T has 
been shown to rescue some effects of the hypertrophic cardiomyopathy associated 
R145G mutation69 suggesting the actions of each region are coupled. That same group 
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suggests these two regions have an evolutionary relationship and came about as a 
result of gene duplication. This hypothesis will be expounded on later. 
 
 
Figure 10: Sequence alignment of the C-terminus of TnT (pink) and the inhibitory region 
of TnI (blue). TnT and TnI have extensive interaction to form the IT-Helix (shown on 
left). Immediately adjacent to the IT-Helix is the C-terminus of TnT and the inhibitory 
region of TnI. The inhibitory region is more specifically defined as residues 137-148. 
Blue letters indicate basic amino acids. Underlined letters indicate known hypertrophic 
cardiomyopathy associated amino acids.  
 
The possible interaction between the C-terminus of troponin T and tropomyosin 
is also a focus of our work. A second troponin T-tropomyosin interaction (T2) is present 
between residues within the C-terminal region of troponin T (residues 201-288) and a 
region near C190 of tropomyosin 70. The residues within the C-terminal region of 
troponin T that are involved in this second tropomyosin interaction consists of either 
residues 197-239 71 or the C-terminus (residues 272-288) 43.  
Chymotryptic fragments of troponin T, residues analogous to cardiac residues 
272-288, were identified as being involved in binding to tropomyosin72. That group used 
affinity chromatography and cosedimentation assays to show that the troponin T T1 
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fragment had an affinity for actin indistinguishable from whole troponin T. The troponin T 
T2 fragment (cardiac residues 188-288) had an affinity for actin 20% of that of whole 
troponin T. A fragment of troponin T T2 (cardiac residues 188-271) missing an 
additional fourteen residues from the C-terminus had an affinity for actin 10% of that of 
whole troponin T. Further chymotryptic truncation from the C-terminus of this fragment 
did not further reduce the affinity.  
Another group measured the fluorescence change of an N-(1-anilinonaphth-4-
yl)maleimide (ANM) probe on C190 of tropomyosin to measure the binding of troponin 
T73. A fragment consisting of residues analogous to cardiac residues 185-288 caused a 
fluorescence change indistinguishable from that produced with whole troponin T. A 
troponin T fragment containing residues analogous to cardiac residues 185-256 did not 
produce any appreciable fluorescence change of the ANM probe on tropomyosin. This 
suggested residues 257-288 of TnT were responsible for the ANM fluorescence 
change. 
Using crosslinking of chymotryptic fragments of troponin T, residues analogous 
to cardiac residues 185-256 were identified as being involved in the C-terminal region 
interaction with tropomyosin74. Interestingly, the crosslinking efficiency was 1.7-fold 
greater at lower calcium concentrations suggesting this interaction is calcium 
dependent. Using monoclonal antibody competition experiments, residues analogous to 
cardiac troponin T residues 197-239 were identified as being involved in the C-terminal 
region of troponin T interaction with tropomyosin71. 
Each of these studies attempting to identify either the binding partner of the C-
terminus of troponin T or the second tropomyosin binding region of troponin T have 
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important limitations that should be considered. Many of these studies utilize 
chymotryptic fragments of troponin T to resolve the specific binding region of troponin T 
to resolve the specific binding region to tropomyosin. The fragments used are often 
missing half of the total length of troponin T and are sometimes as short as 20 residues. 
These smaller peptides are necessary in these types of assays to attempt to resolve the 
binding to a narrow stretch of residues, but the effect on the overall structure should be 
considered. It is questionable whether those peptides fold as they would in whole 
troponin T and thus might interact differently outside of its native conformation. 
 In addition, most of these binding studies were conducted with just a single 
component of the regulated actin complex. These studies attempting to measure the 
interaction between troponin T fragments and tropomyosin for instance, only included 
those proteins in the absence of the other likely potential interacting proteins including, 
actin, troponin I, and troponin C. Similarly, these isolated systems and corresponding 
limitations are often necessary for the particular method, but the limitation should be 
considered, and we should be skeptical of the conclusions.  
The second binding site of tropomyosin is believed to include or be near 
tropomyosin C190. Fluorescence of an ANM probe on C190 of tropomyosin73 was 
measured to determine how the fluorescence changed in response to addition of 
fragments of troponin T. The conclusions from that experiment are limited by only 
considering C190 of tropomyosin as the binding site. In addition to the previous 
limitations described for fragments of troponin T, the ANM C190 tropomyosin 
experiment may be biased toward regions that bind close to that tropomyosin location.  
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Fragments of troponin T that bind at a location further from C190 of tropomyosin 
would produce less fluorescence change but may still bind tropomyosin. Additionally, 
many of these studies are using fragments produced from skeletal troponin. Though the 
C-terminus region that we are concerned with is highly conserved between skeletal and 
cardiac troponin T, regions upstream from the C-terminus are less conserved. Most 
notably, the N-terminal extension is only present in cardiac troponin T. 
 Fluorescence resonance energy transfer (FRET) is used for identifying regions of 
proteins that interact by determining the distance between two different residues. 
Multiple groups have used energy transfer measurements to identify the closeness of 
different locations between troponin subunits, actin, and tropomyosin. FRET 




Table 1: Selected distances measured within Actin-tropomyosin-troponin using FRET 
Source Donor Acceptor Ca2+ Distance (Â) 
75 TnI 151 Phalloidin - 48±1 
75 TnI 151 Tpm 190 - 52±1 
75 TnI 151 Actin C374 - 45±2 
34 TnT 275* Actin C374 - 29.6±0.4 
76 TnT 275* Tpm146 - 44.1 
76 TnT 275* Tpm160 - 38.6 
76 TnT 275* Tpm174 - 36.1 
76 TnT 275* Tpm190 - 35.7 
77 TnT 276 TnI 145 - 28.2 
77 TnT 276 TnI 151 - 44.7 
77 TnT 288 TnI 145 - 39.6 
77 TnT 288 TnI 151 - 50.1 
34 TnT 275* Actin C374 + 36.6±0.2 
76 TnT 275* Tpm146 + 46 
76 TnT 275* Tpm160 + 41.8 
76 TnT 275* Tpm174 + 41.6 
76 TnT 275* Tpm190 + 41.6 
77 TnT 276 TnI 145 + 34.3 
77 TnT 276 TnI 151 + 53.6 
77 TnT 288 TnI 145 + 39.5 
77 TnT 288 TnI 151 + 51.4 
*Skeletal troponin used. Skeletal 250 is most analogous to cardiac 275. Skeletal 244 is 
most analogous to cardiac 269 
  
Using FRET measurements, the C-terminal residues 271-288 were shown to be 
unfolded in both the low calcium and saturating calcium states77. However, the C-
terminus was more unfolded when calcium was present77. This suggested the region’s 
function is calcium dependent and the region extends a greater distance at saturating 
calcium. Based on the evidence that the C-terminus of troponin T interacts with 
tropomyosin, this suggests that the C-terminus would stretch a greater distance to 
interact with tropomyosin at saturating calcium. This supports the evidence from the 
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high resolution structure48 showing that tropomyosin is further from troponin at 
saturating calcium concentrations. At low calcium concentrations, tropomyosin would be 
held closer to troponin because the C-terminus of troponin T is in a less extended state.  
The FRET between skeletal residue C250 (analogous to cardiac 279) troponin T 
and actin residue Q41 showed a 93% transfer efficiency at a very low calcium 
concentration34. This was the higher than any other efficiency measured between the C-
terminus of troponin T and tropomyosin. The efficiency decreased (increased distance) 
when calcium was increased suggesting the C-terminus dissociates from that region of 
actin at higher calcium concentrations 34.  
Additionally, the distance between troponin T C250 (cardiac 279) and C190 of 
tropomyosin was shown to increase at saturating calcium34. This suggests as described 
before, that the C-terminus either dissociates from tropomyosin at saturating calcium 
concentrations or takes on an extended conformation to span the greater distance 
observed between the two regions.  
Identifying the functional significance of residues within the C-terminus of 
Troponin T 
Cardiomyopathy associated mutations in troponin subunits expose the structure-
function relationship of these proteins. Any structural change in troponin, tropomyosin or 
actin, either from mutation or post-translational modification, can result in functional 
changes including effects on calcium sensitivity, force generation, crossbridge cycling 
rate, and calcium cooperativity. One of the primary goals of many labs, ours included, is 
to investigate these structural “hot spots” where mutations are most detrimental to the 
structure and function of these proteins. 
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 Over 100 troponin mutations associated with cardiomyopathy have been 
characterized in terms of their effect on calcium sensitivity, force generation, 
crossbridge cycling rate, and calcium cooperativity to understand how these mutations 
lead to disease. A summary of these investigated mutations can be found elsewhere5,44. 
Identifying the functional effects of these different regions allows us to better understand 
the function of different regions, regions with shared functions, and key locations for 
targeting with sarcomeric modulators.  
The calcium sensitivity, force generation, crossbridge cycling rate, and calcium 
cooperativity resulting from cardiomyopathy mutations can be described in terms of their 
distribution between the blocked (B), closed (C) and open (O) states at very low and 
saturating calcium concentrations. Restoring cardiac function is not as simple as 
correcting just the calcium sensitivity or force generation; it is necessary to fix every 
aspect that is disrupted. We believe this can be done by restoring the normal actin state 
distribution when it is affected. We must understand how regions of troponin influence 
the action state distribution to identify how we might exploit those regions to restore the 
distribution.  
Evidence from our lab shows a substantial effect of mutation within the C-
terminus of troponin T on the actin state distribution. Elimination of the terminal fourteen 
residues of the C-terminus of troponin T eliminates the blocked state at very low calcium 
concentrations and stabilizes the open state at saturating calcium concentrations78. This 
apparent function is novel to our understanding of regulation by troponin and may be an 
ideal target for sarcomeric modulators. One major goal of this project is to identify how 
mutation in this region disrupts functional outcomes. 
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Probing the structure-function relationship of mutation in the C-terminus of 
Troponin T 
The functional outcomes of mutations are grounded in disruption of structural 
relationships. In regions where structure and interactions are known, it is simpler to 
hypothesize and test mechanisms that describe how mutations disrupt function. The C-
terminus of troponin T is absent from the crystal structure of troponin and its binding 
partner is unknown. This makes identifying these mechanisms difficult. We investigated 
the distances between the C-terminus and other thin filament locations using 
fluorescence resonance energy transfer (FRET) to identify possible interactions. The 
second major goal of this project is to identify interactions of the C-terminus of troponin 
T and hypothesize a mechanism for its function.  
 There are many FRET measurements published for distances between different 
actin-tropomyosin-troponin locations and those most relevant to this project are shown 
in Table 1. Some of those distances have been used previously to map the crystal 
structures of actin, tropomyosin, and troponin onto one another to generate a model of 
their complex. Unfortunately, those modeled complexes are missing the C-terminus of 
troponin T. We ultimately wish to use our acquired distances, along with those obtained 
in other labs, to map the location of the C-terminus of troponin T into a model of actin-
tropomyosin-troponin
 
Chapter 2: Experimental Methods 
Protein Preparation 
 Skeletal actin, skeletal myosin, skeletal myosin S1, bovine cardiac ether powder, 
bovine cardiac troponin, bovine cardiac tropomyosin, human cardiac troponin C, human 
cardiac troponin I, human cardiac troponin T, and reconstituted human cardiac troponin 
were prepared by a standard method (Appendix B: Protein Preparation and Protocols). 
Mutant constructs of troponin T were prepared by Dr. Bill Angus and Dr. Li Zhu. 
Acrylodan, pyrene, DABMI, and IAEDANS labelling was performed by standard 
methods with modifications where necessary to improve yield (Appendix B: Protein 
Preparation and Protocols). Verification of troponin and tropomyosin purity was 
completed using SDS PAGE gels with a molecular weight marker and by measures of 
myosin ATPase regulation. Protein concentrations were determined photometrically or 
using a Lowry assay (Appendix B: Protein Preparation and Protocols). 
 
Actin stimulation of myosin ATPase Activity 
Myosin S1 hydrolyzes ATP at a low rate in the absence of actin. Myosin ATPase 
activity is stimulated by interaction with actin in the O state. The myosin ATPase 
produces ADP and inorganic phosphate from ATP. An ATPase reaction is initiated by 
adding S1 to a mixture containing 32P labelled ATP. This mixture might also contain 
actin, actin-tropomyosin, or actin-tropomyosin-troponin to measure how different 
combinations of proteins activate or inhibit stimulation of ATPase activity.  
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For our ATPase assays, the following protocol was followed unless otherwise 
specified: Rabbit skeletal actin and bovine cardiac tropomyosin were allowed to mix at 
least twelve hours. Troponin was added approximately thirty minutes before initiating 
the reaction to provide adequate time to bind. The Actin-tropomyosin-troponin ratio was 
usually 7:2:2 to ensure saturation unless specified otherwise. The reaction buffer 
typically contained 31 mM KCl, 10 mM MOPS pH 7, 3 mM MgCl2, 0.5 mM CaCl2, and 1 
mM DTT. Solutions were either 1 mL or 0.5 mL final volume and prepared in 4 mL 
Teflon beakers. The reaction mixture was moved to a water bath set to 25 degrees C 
over a stir plate. 1 mM 32P ATP was added and the temperature allowed to equilibrate at 
least two minutes. The reaction was initiated upon addition of 0.1 µM Myosin S1. 
At different time points throughout the reaction, an aliquot of the reaction mixture 
(typically 100 µL) was removed into a disposable glass culture tube and the following 
steps were completed subsequently without pause: add 0.4 ml of 1.5 N HCl, 1.5 mM 
NaPO4, 0.2 ml of 1.4 N H2SO4, 4.3% Silicotungstic acid, 1 mL of 1:1 isobutanol:benzene 
and 0.2 ml of 5% ammonium molybdate. The mixture was then vortex mixed for exactly 
thirty seconds. The generation and movement of free phosphate in the process is 





Figure 11: ATPase Experiment Scheme 
 
The purpose of the HCl is to lower the pH and stop the reaction. The Pi in NaPO4 
functions to help extract the 32Pi. The silicotungstic and sulfuric acid precipitate the 
proteins to keep them in the aqueous layer. The molybdate functions to complex with 
the released Pi. The butanol-benzene is present to provide an organic layer to extract 
and isolate the phosphomolybdate complex. 
 0.2 mL was typically removed from the upper organic phase of each resultant 
aliquot mixture and added to a scintillation vial. 5 mL of Scintiverse scintillation fluid was 
typically added to the scintillation vial. The extracted 32Pi was then counted for each of 
the aliquots. A slope is measured from a plot of time versus 32Pi count for each reaction 
(Appendix C: Supplementary Data). 
A scintillation count of 1 mM 32Pi count must be determined to normalize the data 
and calculate the ATPase rate. That value was typically determined by counting a 20 µL 
aliquot directly from a mixture following reaction completion without extracting the 32Pi 









The ATPase rate is also determined each day from an experiment containing 
myosin S1 alone in the absence of actin. This rate is subtracted from all of the actin 
stimulated myosin ATPase rates to correct for ATP hydrolysis that was not the result of 
stimulation by actin. The fraction of actin in the open state was calculated by dividing 
the observed ATPase rate my the rate when actin is stabilized fully in the active state by 
N-ethylmaleimide modified myosin S1 or A8V∆14 troponin78. That rate was determined 
to be approximately 6.5 times the unregulated actin rate. 
Stopped Flow Kinetics 
 Stopped flow kinetics was used to monitor fluorescence and light scattering 
changes of reactions from less than two milliseconds after rapid mixing. Two solutions 
are loaded into syringes, then injected into cells. Upon reaction initiation, a volume 
within each cell is rapidly forced through a mixer then into an optically clear cubical 
reaction cell. Light of a specified wavelength dependent on the transition being 
monitored is emitted through one face of the cell. Fluorescence or light scattering are 
measured at a right angle to the path of the emitted light. A schematic of the stopped 




Figure 12: Schematic of stopped flow apparatus 
 
Acrylodan ATPchase Experiment or Dissociation of Myosin S1 from Regulated 
actin 
Rapid dissociation of myosin S1 from regulated actin by addition of ATP 
(ATPchase) was monitored in a stopped flow spectrometer. Actin is stabilized in the fully 
open (O) state by formation of myosin crossbridges in the absence of ATP. Reaction 
solution one contained the proteins actin, tropomyosin, troponin, and myosin S1 
typically in a 7:2:2:7 molar ratio. Reaction solution two contained a 1000-fold excess of 
ATP over actin.  
Upon mixing with ATP, myosin S1 rapidly dissociates from actin. Actin the 
redistributes into a mixture of the closed and blocked states depending on the 
regulatory proteins present. Tropomyosin was labeled with a fluorescent acrylodan 
probe on cysteine-190 (Figure 14). The chemical structure of the acrylodan probe is 
shown in Appendix C: Supplementary Data. The solution was excited with light of 391 




For actin filaments containing wild type troponin at very low calcium, a rapid 
fluorescence decrease was observed followed by a slower fluorescence increase 
(Figure 13). We attribute the rapid initial decrease in fluorescence to a transition from 
the open (O) to closed (C) state. The slower increase in fluorescence is attributed to the 
closed (C) to blocked (B) transition79. 
 
Figure 13: ATPchase experiment of actin regulated by wild type troponin. Initial 
decrease in fluorescence is attributed to open to closed state transition and the rate is 
greater than 200/second. The following increase in fluorescence is attributed to the 





The amplitude of the closed to blocked state transition can be divided by the 
amplitude of the wild type transition to produce a relative blocked state value using 
equation 2. The normalized amplitudes for actin regulated by troponin variants tells us 
how a troponin variant effects the stability of the blocked state as summarized in Table 
2. 
 





Table 2: Mutation Effect on Blocked State 
Relative Amplitude Blocked State 
Greater than one Stabilized 
Equal to one Unaffected 
Less than one Destabilized 
Zero Absent 
 
For the ATPchase experiments, rabbit skeletal actin and bovine cardiac 
tropomyosin were allowed to mix at least twelve hours in a typical ratio of 7:2. Solution 1 
typically contained 2 µM Actin, 0.86 µM tropomyosin, 0.86 µM troponin, and 2 µM 
Rabbit skeletal myosin S1. Solution 2 contained 2 mM ATP. 50 mM ATP stocks were 
either made fresh or thawed immediately before use. The reaction buffer contained 152 
mM KCl, 20 mM MOPS pH 7, 4 mM MgCl2, 2 mM EGTA, and 1 mM DTT. Each solution 
was typically 1 mL in volume and prepared in 4 mL Teflon beakers.  
The actin-tropomyosin solution was mixed with troponin on ice and typically 
allowed to incubate at least thirty minutes before loading into the stopped flow. After 
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injecting into cells, solutions were allowed to equilibrate in temperature for two minutes 
before mixing. Upon mixing solution 1 and 2 in equal parts in the stopped flow, the final 
concentrations of each protein in the reaction mixture are halved. 
 
Myosin S1 Binding to Pyrene Actin 
 The rate of binding of myosin S1 to actin is dependent on the regulatory proteins 
bound to actin and the distribution of actin between the blocked, closed and open 
states. This experiment takes advantage of the different rates of binding to the different 
states of actin. In the S1 binding pyrene actin experiment, myosin S1 was rapidly mixed 
with regulated actin (Actin-tropomyosin-troponin) in a stopped flow apparatus.  
Actin was fluorescently labeled with a pyrene probe on cysteine-374 (Figure 14). 
The chemical structure of the pyrene probe is shown in Appendix C: Supplementary 
Data This experiment can be performed with either actin or myosin S1 in excess to 





Figure 14: Structure of the Actin-tropomyosin-troponin complex as generated from 
molecular modelling simulations  from crystal structures of actin, tropomyosin and 
troponin39. Only two monomers of actin (orange) are shown). One pseudorepeat of 
tropomyosin is shown (yellow). Troponin T (pink), Troponin I (Blue), Troponin C (green). 
The pink sphere indicates the approximate location of the C-terminus of troponin T; the 
last 16 residues are missing from the troponin T crystal structure. The residue colored 
black in actin is residue C374. The residue colored grey in tropomyosin is residue C190. 





Myosin S1 Binding to Pyrene Actin. Excess Actin. 
Reaction solution one contained the proteins actin, tropomyosin, and troponin 
typically in a 7:2:2 molar ratio. Reaction solution 2 contained myosin S1 in the same 
buffer as solution 1. The solution was excited with either a monochromator set to 365 
nm wavelength or a 360 nm LED and observed through a 370/400/475 filter. After 
mixing, the final concentration of myosin S1 was 10-fold lower than the actin 
concentration. The rate of myosin binding to actin is proportional to the distribution of 
regulated actin states. By combining results at both low and high calcium concentration, 
qualitative information regarding effects on actin state distribution can be inferred (Table 
3). 
 
Table 3: Evidence from S1 Binding Experiment on State Distribution 
Relative Rate in EGTA* Relative Rate in Calcium* State Distribution 
Faster Faster Stabilized Open State 
Slower Slower Stabilized Blocked State 
Faster Slower Stabilized Closed State 
Slower Faster Destabilized Closed State 
*Relative to Wild Type Regulated Actin 
 
This experiment is a commonly used method of calculating the actin state 
distribution at low calcium concentrations. From ATPase experiments at very low 
calcium concentrations, the open state is negligibly occupied, therefore actin is primarily 
distributed between the closed and blocked states. Equation 3 is used to calculate the 









M is the fraction of actin in the open (O) state as determined by ATPase 
experiments and is typically about 0.01. KB is calculated from equation 4. KEGTA is the 
rate of the fluorescence transition when the calcium concentration is very low. Kcalcium is 
the rate of the fluorescence transition at saturating calcium concentrations. This value is 
thought to be equivalent for any troponin species. 
 







 With the fraction of the open (O) and closed (C) state known, the fraction in the 
blocked (B) state can be calculated from the conservation of mass as shown in equation 
5 where C is the fraction in the C state. 
 
Equation 5:   Fraction B state = 1 − C − O 
 
For wild type troponin regulated actin at low calcium concentrations, a decrease 
in fluorescence is observed upon addition of myosin S1 (Figure 15). Before addition of 
myosin S1 under low calcium conditions, actin is primarily in the blocked and closed 
states and very little actin is in the open state. It is believed that the fluorescence 
change corresponds to a myosin S1 binding to each state of actin. There is general 
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agreement that myosin S1 binds more rapidly to the closed and open states than to the 
blocked state. 
 
Figure 15: S1 Binding experiment using actin regulated by wild type troponin 
 
For wild type troponin regulated actin in the presence of calcium, a faster 
decrease in fluorescence is observed compared to the experiment at low calcium 
concentrations. This is true because calcium removes troponin induced myosin ATPase 
inhibition and destabilizes the blocked state resulting in higher populations of the closed 
(C) and open (O) states to which myosin S1 more rapidly binds.  
 
Myosin S1 Binding to Pyrene Actin. Excess Actin. Excess Myosin S1. 
Measuring the rate of binding of myosin S1 to pyrene actin with S1 in excess can 
also be used to measure the relative blocked state distribution of actin as it maintains 
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pseudo first order kinetics. These traces are more complex due to the cooperative 
nature of myosin S1 binding when in excess. As S1 binding increases, the O state 
population and the rate of binding increases as well. An initial lag in the fluorescence 
time courses where the rate begins slower before increasing represents an initial 
population of actin that is in the blocked state and unavailable for myosin S1 
binding30,80.  
This initial blocked state population of actin inhibiting myosin S1 binding is 
converted to closed or open actin by the cooperative activation by myosin S1 binding in 
excess31,81. Once in the closed or open state, myosin S1 can bind those sites. Because 
of the initial unavailability of binding to those blocked sites, the exponential phase 
following the lag is slowed. The blocked state can be measured using this method by 
the relative change in both the duration of the lag phase or the rate of the exponential 
phase that follows.  
 
Fluorescence Resonance Energy Transfer 
Fluorescence resonance energy transfer (FRET) is a measure of the transfer of 
energy between two light sensitive molecules. Transfer of energy can occur when the 
fluorescence spectra of one molecule (Donor) overlaps with the absorption spectra of 
another molecule (Acceptor) and when the molecules are close enough to interact. 
When FRET occurs, the acceptor absorbs the energy from the donor molecule and 
releases the energy through fluorescence at a higher wavelength or as heat. A 
decrease in donor fluorescence indicates that the fluorescence has been quenched by 
the acceptor. By attaching a FRET donor and acceptor to two known locations within a 
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protein or protein complexes, the closeness of those locations can be measured by 
quenching of the donor fluorescence. The absolute distance between the donor and the 
acceptor probe is a function of the efficiency. The absolute distance can also be 
calculated by also obtaining the quantum yield, overlap integral, dipole orientation 
factor, and refractive index. 
We attached FRET pairs between different locations within the actin-
tropomyosin-troponin complex to identify the closeness of different regions. For each 
FRET pair, the experiment was performed at very low and at saturating calcium 
concentrations to measure if the regions distances were dependent on the calcium 
concentration. For each experiment, two solutions are prepared; one solution contains 
both the donor and acceptor probe, whereas the other contains only the donor probe. 
This is necessary to determine to what extent the acceptor (DABMI) can quench the 
donor (IAEDANS) fluorescence.  
In the FRET experiments, solutions containing actin-tropomyosin and troponin 
were mixed in the dark. Actin-tropomyosin were mixed at least 12 hours prior to mixing 
with troponin for experiment use. Phalloidin was additionally added to stabilize the actin 
before or along with mixing with tropomyosin.  
The FRET experiments contained 2 µM skeletal actin, 0.51 µM bovine cardiac 
tropomyosin, 0.29 µM troponin. The troponin concentration was chosen for 
stoichiometric binding to actin. The donor probe is on troponin in each FRET experiment 
and any excess troponin that is not bound to actin cannot be quenched by the acceptor 
probe. The tropomyosin concentration was chosen as a titration with DABMI 
tropomyosin produced maximal quenching at that concentration (Appendix C: 
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Supplementary Data). The very low calcium concentration solutions were prepared with 
2 mM EGTA and no added calcium. The saturating calcium solutions were prepared by 
adding 0.1 mM CaCl2.  
After mixing with troponin, the solutions were given 30 minutes to mix on ice. 
During this time, the Fluoromax-4 Spectrofluorometer cells were ensured to be clean 
and the spectrofluorometer was turned on if necessary and temperature of the water 
bath was ensured to be at 25° C. After this time, the mixed solution to be measured was 
removed from ice and placed in a water bath at room temperature in the dark for ten 
minutes. This was done to prevent condensation when added to the spectrofluorometer 
cells. The solutions were added to the cells and another ten minutes were allowed to 
pass before taking measurements.  
The donor IAEDANS is excited at 336 nm and the fluorescence is measured from 
360 to 640 nm. The acceptor DABMI is nonfluorescent and can absorb energy from 
IAEDANS fluorescence but does not itself fluoresce. Each plot of fluorescence versus 
wavelength for the IAEDANS-DABMI pair was integrated to obtain the area under each 
plot. The efficiency was calculated from these integrated values. The exact protocol for 
taking measurements can be found in Appendix B: Protein Preparation and Protocols.  
A representative plot of the raw FRET data is shown in Figure 16. The top panel 
shows a plot of the fluorescence versus emission wavelength for either donor alone (D) 
or donor with acceptor (DA). The acceptor used in our experiments is nonfluorescent 
and quenches the donor fluorescence when nearby. As a result, the plot DA has 
diminished fluorescence as it has quenched some of the fluorescence from plot D. The 
area under each of these plots is determined by integrating (after subtracting the 
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baseline if necessary). This integration process is detailed in Appendix B: Protein 
Preparation and Protocols.  
 
Figure 16: Representative FRET data. D indicates donor in the absence of acceptor 




The efficiency of transfer is a function of these integrated values and the labeling 
percentage of the acceptor probe. The efficiency is calculated according to Equation 6 
where DA is the integrated value when the acceptor probe is present and D is the 
integrated value in the absence of acceptor. The process of determining the distance 
from these efficiency measurements is described in Appendix B: Protein Preparation 
and Protocols. 










Chapter 3 Residues within the C-terminus of Troponin T stabilize 
inactive B state and destabilize active O state 
 
Part 1: Identification of the residues within the C- terminus of troponin T that are 
responsible for formation of the blocked (B) state at low Ca2+. 
Deletion of the fourteen C-terminal residues of Troponin T significantly reduces 
or eliminates the blocked state of actin at very low calcium concentrations. This has 
been demonstrated by our lab using three different methods78,82. In measures of 
ATPase activity, actin regulated by Δ14 troponin T at very low calcium concentrations 
produces an ATPase rate higher than that of wild type regulated actin83. Since ATPase 
activity only occurs when actin is in the active O state, this result suggests that Δ14 
troponin T causes a redistribution of actin from the inactive B state to C state. The 
equilibrium between the C and O states results in an increase in the O state.  
In measures of equilibrium binding, wild type troponin regulated actin initially has 
a low affinity for myosin S1. Cooperative binding of myosin S1 converts binding sites 
from low affinity to high affinity sites. Those low affinity sites are absent with Δ14 
troponin T regulated actin82. Myosin S1 binds with a high affinity without requiring 
cooperative binding. This suggests the blocked state is diminished or eliminated by Δ14 
troponin T. 
Reduction or elimination of the blocked state by Δ14 troponin T was shown by an 
independent method developed in our lab. This method measures the relative 
occupancy of the blocked state through a fluorescence change in an acrylodan probe 
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on tropomyosin. Acrylodan tropomyosin bound to wild type troponin regulated actin 
produces a fluorescence change indicative of a closed to blocked state transition upon 
myosin S1 dissociation by ATP. For actin filaments regulated by Δ14 troponin T, this 
acrylodan tropomyosin fluorescence change is absent indicating that transition into the 
blocked state is reduced or absent79,83. 
Reduction or elimination of the blocked state by Δ14 troponin T was also shown 
by a commonly used method of measuring the fluorescence change of a pyrene probe 
on actin78. This probe is thought to decrease in fluorescence when myosin S1 binds to 
the closed or open states. Myosin S1 is believed to bind to the closed and open states 
more rapidly than to the blocked state. Using this method, we showed that Δ14 troponin 
T produced a higher rate of binding indicating a diminished blocked state population. 
The fourteen C-terminal residues of troponin T are highly conserved across 
isoforms and species. The high conservation along with the results from analysis of Δ14 
troponin T made clear the significance of this region. Our next question was, which of 
those residues are responsible for this effect and why? To help answer this question, 
we developed a series of truncation mutants missing varying numbers of residues from 
the C-terminus of troponin T. These included ∆4, ∆6, ∆8 and ∆10 troponin T. The idea 
behind the generation of this series of mutants was to measure how each affected the 
state distribution of actin. By comparing the relative change between successive 
truncation length, we would be able to resolve the specific residues within the C-
terminus of troponin T that are important for its function. Some of this work was 
presented previously44. Since then, we have exhaustively confirmed that work by 
completing additional trials of those experiments with the new protein preparations, 
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performing those analysis with the remainder of our truncation series, and performing 
additional assays with the entire truncation series. Our updated progress is presented 
below, beginning with the truncation series effect on the blocked state of actin. 
We performed three independent assays of blocked state accessibility by actin 
regulated by wild type troponin and each of our five truncation mutants, ∆4, ∆6, ∆8, ∆10 
and ∆14 troponin T. It should be noted here, that any time troponin is present in an 
experiment, it is assumed that tropomyosin is also present. At equilibrium, 
stoichiometric binding of myosin S1 to actin stabilizes actin nearly 100% in the active O 
state. Rapid addition of excess ATP causes the myosin S1 to bind ATP and rapidly 
dissociate from actin. At very low calcium concentrations, the active O state is rapidly 
depopulated and actin redistributes between a mixture of the closed and blocked state. 
Two fluorescence changes can be resolved for wild type troponin regulated actin 
following this dissociation of myosin S1 at the concentrations and conditions of our 
assay. 
The rapid initial decrease in fluorescence is attributed to transition of actin from 
the active O state to the closed C state79. This fluorescence change occurs with a rate 
>100/sec but slower than the change in light scattering upon S1 dissociation. For wild 
type troponin regulated actin at very low calcium concentrations, a subsequent increase 
in fluorescence is observed. We attribute this change in fluorescence to a transition 
from the closed C state to the blocked B state. The observation that this increase in 
fluorescence is absent at saturating calcium concentrations further supports this 
transition is a direct observation of entry into the blocked state. It was previously 
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observed that ∆14 troponin T similarly eliminated this florescence increase 
corresponding to reduction or elimination of the blocked B state47 
Figure 17 shows the results of our analysis of the truncation series effect on the 
entry of actin into the blocked B state. Figure 17A shows the time course of acrylodan 
tropomyosin fluorescence for actin regulated by WT (1), Δ10 (2) and Δ14 (3) troponin T. 
As we’ve shown previously, WT (1) exhibits a fluorescence increase whereas for Δ14 
(3) regulated actin, the transition is absent. Interestingly, for Δ10 (2) regulated actin, the 
transition can still be observed, but the magnitude of the change is diminished. We 
attribute this decrease in the magnitude of the fluorescence change to a decrease in 
redistribution of actin into the blocked B state.  
Figure 17B shows a plot of the magnitude of each of the troponin T truncations 
relative to the magnitude observed with wild type troponin regulated actin. Each 
successive truncation results in successive decrease in magnitude of that fluorescence 
change, all of which produce a fluorescence change amplitude that is statistically lower 
than that produced with wild type troponin regulated actin.  
There was insignificant change in the apparent rate constant for the transition 
from the C state to the B state (k7 + k8) between WT troponin and each of the 
truncations Δ4-10 troponin T. As the transition is absent for ∆14 troponin T regulated 
acting, no rate could be measured. The most significant effect on the amplitude was 
observed upon elimination of the first four residues from the C-terminus. Elimination of 
those four residues eliminated approximately half of the B state population accessed by 
wild type troponin regulated actin. Though those terminal four residues appear 
particularly important, we conclude from this assay that most or all of the residues within 
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the terminal fourteen C-terminal residues of troponin T are to some extent important in 
maintaining the blocked B state.  
One limitation of this assay is that it only produces a measure of the blocked 
state relative to the wild type standard. At the moment, there is not an agreement on the 
fraction of wild type troponin in the blocked state at low calcium concentrations. By 
using a standard value of the blocked state population of wild type troponin at low 
calcium concentrations, the absolute B state population can be calculated. An external 
assay must be trusted to convert that relative blocked state population into an absolute 
population value. One method of obtaining a standard value for the blocked state as 




Figure 17: Formation of the inactive B state seen by acrylodan-tropomyosin 
fluorescence. A. Time courses of acrylodan fluorescence changes for actin regulated by 
wild type (1), ∆10 (2) and ∆14 troponin T (3) following the rapid detachment of myosin 
S1 in the absence of Ca2+ at 10 °C. Traces shown are averages of at least three 
different measurements. B. Relative fluorescence amplitude for actin filaments 
containing wild type and truncated troponin T. The associated apparent rate constants 
were, 6.8, 6.9, 6.5, 7.4, 6.1 per sec for the wild type through ∆10 mutants, respectively. 
No rate constant could be determined for Δ14. At 10°C, 2 µM actin, 0.86 µM 
tropomyosin, 1.4 µM troponin and 2 µM S1 in 20 mM MOPS, 152 mM KCl, 4 mM MgCl2, 
1 mM dithiothreitol and 2 mM EGTA was rapidly mixed with 2 mM ATP, 20 mM MOPS, 
152 mM KCl, 8 mM MgCl2, 1 mM dithiothreitol and 2 mM EGTA. Acrylodan was excited 
using a monochromator at 391 nm and 0.5mm slit width. The fluorescence was 
monitored through a 435/451/460 filter.  
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Myosin S1 binds to regulated actin at a faster rate at saturating calcium than at 
very low calcium concentrations. From this we can conclude there is a difference in the 
rate of binding between the states of actin 30,84. A pyrene probe on actin is used to 
measure this difference in binding as it is believed to only exhibit a fluorescence change 
when myosin S1 binds to the closed or open states30. Though we will present new 
evidence concerning the rates of binding to each actin state later, it is generally 
accepted that myosin S1 binds the C and O states more rapidly than to the B state. The 
rate of fluorescence change of pyrene actin in pseudo-first order conditions with either 
S1 or actin in excess presents two means of measuring the relative blocked state 
distribution.  
Figure 18A shows the time course of myosin S1 binding to excess pyrene actin 
regulated by tropomyosin and either WT (1), ∆10 (2), or ∆14 troponin T troponin at very 
low calcium concentrations. Because the fluorescence change only occurs for S1 
binding to the C or O states and the O state is population is negligible at low calcium 
concentrations, the fluorescence change is essentially a measure of S1 binding to the C 
state. A slower rate corresponds to a greater B state population. Figure 18B shows the 
rates of the fluorescence transition for each of the truncation mutants. Stepwise 
truncation from the C-terminus resulted in a graded elimination of the blocked state 
where the relative loss of blocked state corresponded with the number of residues 
removed. As in the results from the acrylodan experiment above, the first four residues 
from the C-terminus appear disproportionately important to maintaining the blocked 
state than the other 10 C-terminal residues. Removal of those four residues (GRWK) 
resulted in a rate halfway between the rates for wild type and ∆14 troponin T regulated 
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pyrene actin. All of the fourteen C-terminal residues however appear necessary for 
maintaining the blocked state. 
 
Figure 18: Binding of S1 to an excess of pyrene labeled actin filaments containing 
tropomyosin and troponin in the absence of ATP at a very low Ca2+ concentration. A. 
Averaged time courses of binding to actin-tropomyosin containing wild type (1); Δ6 (2); 
and Δ14 (3) troponin T. Dashed lines are single exponential fits. B. Observed rate of 
binding of S1 to actin-tropomyosin containing troponin with different mutants of troponin 
T. Error bars shown are standard deviation for at least 5 experiments. At 25°C, 4 μM 
pyrene-actin (40% labeled), 0.86 μM tropomyosin and 0.86 μM troponin was rapidly 
mixed with 0.4 μM myosin S1 in 20 mM MOPS, 152 mM KCl, 4 mM MgCl2, 1 mM 
dithiothreitol and 2 mM EGTA. Pyrene was excited using a monochromator at 365nm 
with 0.5 mm slit width. The fluorescence was monitored through a 400nm midpoint long 
pass filter.  
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 Figure 19A shows the time courses for the binding of excess myosin S1 to 
pyrene actin regulated by wild type (1) or ∆14 troponin T (2). For each truncation, a 
double exponential was fit to the more rapid phase following the lag. The second phase 
of that double exponential was the same for each mutant. A higher rate indicates a 
lower initial population of the blocked state. 
Figure 19B plots the duration of the lags for wild type troponin and the truncation 
mutants ∆4, ∆6 and ∆14. A double exponential was used to resolve the slower initial 
(lag) phase from the more rapid phase. The time at which the first exponential ends was 
recorded as the lag time. Successive truncation results in a corresponding reduction in 
the lag time indicating a decrease in the initial blocked state distribution. A double 
exponential fit could not resolve multiple phases for actin regulated by ∆14 troponin T 
Tn indicating that no lag phase or blocked state could be resolved. Each truncation had 
a statistically lower lag time than wild type troponin.  
Figure 19C plots the rate of the first exponential in that double exponential fit 
corresponding to the rate of transition following the lag phase. A stepwise effect is 
observed where successive truncation results in a corresponding increase in the rate of 
the exponential fit indicating a greater initial accessibility of closed and open actin sites 




Figure 19: Binding of excess S1 to pyrene 
labeled actin filaments containing 
tropomyosin and troponin in the absence of 
ATP at very low Ca2+. A. Averages of ≥ 5 
time courses of S1 binding to actin filaments 
containing troponin with wild type troponin T, 
curve 1 or Δ14 troponin T, curve 2. Dashed 
lines are double exponential fits. B) Lag time 
preceding the exponential phase against 
troponin type. C) Apparent rate constants for 
the major rapid exponential phase of binding 
against troponin variant. Error bars shown 
are standard deviation. Conditions: At 25°C, 
0.2 μM pyrene-actin (40% labeled), 0.086 μM 
tropomyosin and 0.086 μM troponin was 
rapidly mixed with 2 μM myosin S1 in a 
buffer containing 152 mM KCl, 20 mM MOPS 
buffer pH 7, 4 mM MgCl2, 1 mM dithiothreitol 
and 2 mM EGTA. Pyrene was excited using 
a monochromator at 365 nm with 0.5mm slit 
width. The fluorescence was monitored 
through a 400 nm midpoint long pass filter. 
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As described and shown previously (Figure 18), binding of myosin S1 to excess 
pyrene actin allows us to identify the relative effect of troponin mutants on the blocked 
state distribution at very low calcium concentrations. What was not described previously 
is that these measurements are commonly used to calculate the absolute distribution of 
actin across all three states (Equations 5-7). This technique relies on the assumption 
that myosin S1 binds at an equal rate to either the closed or open O state. Since the 
blocked state is absent at saturating calcium concentrations, measuring the rate of 
binding at saturating calcium is thought to be a direct measure of the rate of binding to 
the closed and open states. As such, regardless of the troponin species regulating actin, 
this rate should be equal since in the absence of blocked state, the total combined 
population of closed and open states is maintained. With this standard value of the rate 
of binding to the closed and open state kcalcium, equation 5-7 is used to calculate the 
state distribution at very low calcium concentrations. Our experiments attempting to use 
this method produced an unexpected result. 
We repeated the experiment shown in Figure 19 under the same conditions 
except the calcium was saturating. Figure 20A shows the time course of the 
fluorescence change for WT (1), ∆8 (2), and ∆14 (3) regulated pyrene actin. As stated, 
this commonly used method of calculating the actin state distribution relies on the rate 
at saturating calcium concentrations being unaffected by different troponin mutants. 
Upon fitting these time courses with a single exponential, we found that the rates of 
binding increased as the number of residues in the C-terminus of troponin T was 
reduced and as the population of the open state increased relative to the closed state. 
Figure 20B shows the measured rates of the fluorescence transition for pyrene actin 
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regulated by each truncation mutant at saturating calcium. Because Equation 6 
assumed that the rate of binding to the closed and open states are equal, this equation 
is invalid. The implications of this finding will be discussed in Chapter 5. 
 
Figure 20: Rate of binding of S1 to an excess of pyrene labeled actin filaments 
containing tropomyosin and troponin in the absence of ATP at a very saturating Ca2+ 
concentration. Plots are averages of at least five time courses of binding to actin-
tropomyosin containing wild type (1), Δ8 (2), and Δ14 troponin T (3). Dashed lines are 
single exponential fits of the data. At 25°C, 4 μM pyrene-actin (40% labeled), 0.86 μM 
tropomyosin and 0.86 μM troponin was rapidly mixed with 0.4 μM myosin S1 in 20 mM 
MOPS, 152 mM KCl, 4 mM MgCl2, 1 mM dithiothreitol and 0.1 mM CaCl2. Pyrene was 
excited using a monochromator at 365nm with 0.5mm slit width. The fluorescence was 
monitored through a 400 nm midpoint long pass filter.  
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Part 2: Identification of the residues within the C- terminus of troponin T that are 
responsible for inhibiting formation of the open (O) state at saturating Ca2+ 
 A key observation in our studies is the dual effect of mutation in the C-terminus of 
troponin T on the actin state distribution. The ∆14 troponin T mutant was shown 
previously to affect the blocked-closed state distribution at low calcium concentrations 
and also the closed-open state distribution at saturating calcium. To identify the 
residues within this C-terminus that are most important for stabilizing the open state at 
saturating calcium, ATPase measurements of actin-myosin were made with a series of 
troponin T truncation mutants. Because actin only stimulates ATPase activity in the 
open O state, the rate of ATPase activity is a direct measure of the O state. The ability 
to measure this state directly is of crucial importance to our studies and this technique 
will be reviewed here. 
The ATPase rate was measured for actin regulated by wild type troponin and 
each of the truncation mutants ∆4, ∆6, ∆8, ∆10, or ∆14 troponin T. These data were 
collected across multiple actin, tropomyosin, troponin and myosin S1 preparations as 
well as with different batches of 32P ATP and reagents.  
 Figure 20 is a plot of corrected rates for wild type troponin and each truncation 
mutant. The average from all wild type troponin experiments was found to be 2.4/sec. 
Each truncation produced a statistically higher ATPase rate than wild type troponin. As 
well, ∆14 produced a rate that was significantly higher than WT, ∆4, ∆6 and ∆8 troponin 
T troponin. Though there is no statistical difference between ∆4, ∆6, and ∆10, the 
general trend is that as residues are removed from the C-terminus, the ATPase rate is 
increased. The solid straight line connecting the rate for wild type and ∆14 troponin 
indicates the rate that would be obtained if each residue within the C-terminus 
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contributed equally to maintaining the active O state. As can be seen, each residue 
does not contribute in this way and instead some residues appear disproportionately 
more important. The greatest differences occur between WT and ∆4 and between ∆10 
and ∆14.  
To calculate the O state from these rates, we must know the rate of myosin 
ATPase activity in the presence of actin fully stabilized in the active O state under the 
same condition. This value is typically measured by stabilizing actin fully in the O state 
with binding of a small amount of NEM S1. Our lab has shown that this rate can also be 
obtained in the absence of activating myosin species using the troponin construct 
A8V∆14 Troponin78. This was a very important observation and the significance of this 
finding will be discussed later in the context of the data presented in this dissertation. 
That rate was found previously to be 6.5* the rate of unregulated actin (Baxley 2017). If 
we know the ATPase rate produced under the same conditions by actin stabilized fully 
in the active O state (Vmax), the O state population for any actin-tropomyosin-troponin 
mixture can be calculated by normalizing to that rate (equation 10). These calculated O 
state populations are plotted in Table 3. 
 
Equation 10:  
Fraction O state =  





Figure 21: ATPase rates of myosin S1 in the presence of actin and actin-tropomyosin 
containing troponin with different mutants of troponin T at saturating Ca2+. 
Measurements were made at 25o C and pH 7.0 in solutions containing 1 mM ATP, 3 mM 
MgCl2, 34 mM KCl, 10 mM MOPS, 1 mM dithiothreitol and 0.1 mM CaCl2. The 
concentrations of S1, actin, tropomyosin, and troponin were 0.1, 10, 2.2, and 2.2 µM, 
respectively. The average rate for wild type regulated actin over all experiments was 2.4 
/sec (+/- 0.1). Corrected rate = average of all wild type experiments*(measured mutant 





Table 4: Fraction of actin in the O state for actin filaments at saturating Ca2+ and 
containing various mutants of TnT. 
TnT mutant FOa 











Part 3: HAHA troponin T and ∆14 troponin T exhibit similar functional properties 
as at very low Ca2+ concentration 
 Our truncation study revealed that: 1) the entire C-terminus was required to 
maintain the Blocked state and 2) removal of the entire C-terminus is required for the 
full activating effect. We had previously entertained the idea that the basic residues 
within this region (6 of last fourteen and 7 of last 16 residues) are responsible for this 
regions function. The truncation study affected the state distribution of the blocked and 
open states in a graded manner. Truncation from the C-terminus loosely corresponded 
with removal of those basic residues. Importantly, ∆4 troponin T troponin, which 
removed two basic residues, produced a marked effect in each of our assays.  
We generated a new troponin construct where the seven basic residues within 
the terminal sixteen residues of the C-terminus of troponin T were substituted with the 
neutral amino acid alanine. As the goal of this mutant was to develop a high activity 
construct and since the mutant contained an abundance of alanine substitutions, we 
named this mutant high alanine high activity troponin T (HAHA troponin T) (Figure 22). 
Mass spectrometry was used to verify the amino acid sequence of the purified protein 
(Appendix C: Supplementary Data). 
Additionally, we constructed and analyzed a 289C and S275C troponin T mutant 
that retains the basic amino acids but has an additional Cysteine attached to the C-
terminus and a serine substituted to cysteine at residue 275 respectively. 289C troponin 
T was designed as a control for HAHA 289C to demonstrate that terminal cysteine did 
not appreciably affect function. Both 289C and 275C troponin T were designed with the 




Figure 22: Amino acid sequence of the C-terminus of wild type and HAHA troponin T. 
The ∆4, ∆10, and ∆14 notations and corresponding dotted lines indicated the position at 
which the C-terminus was truncated for the different mutants. The residues indicate in 
blue are the seven basic residues within the terminal sixteen residues. The residues 
indicated in green are the alanine residues that were substituted in place of the basic 
residues. Note the additional C-terminal cysteine on HAHA TnT which was used for the 
attachment of fluorescent probes. 
 
 This construct was developed for three major reasons. Firstly, in order to identify 
how removal of those basic residues affected the state distribution of actin. Secondly, to 
develop a full-length mutant for potential use in fiber studies. Thirdly, to utilize the full-
length open-state stabilizing mutant in fluorescence assays.  
 The HAHA troponin T construct was analyzed by the methods used previously to 
characterize the truncation series. The acrylodan tropomyosin assay was used to 
measure the relative blocked state distribution. Figure 23 shows the time course of the 
fluorescence change of acrylodan tropomyosin upon rapid dissociation of myosin S1 by 
ATP. Actin rapidly transitions out of the open O state and redistributes into the closed 
and blocked states. The closed state produces a low fluorescence whereas the blocked 
state produces a high fluorescence.  
In Figure 23, Curves A and B are for wild type troponin and 289C troponin 
respectively. The 289C mutant produces an amplitude of the closed to blocked 
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transition that is equivalent to that produced by wild type troponin regulated actin. We 
also completed this experiment with 275C troponin T (Appendix C: Supplementary 
Data). Both experiments with 275C and 289C demonstrated that an addition or 
modification to cysteine within the C-terminus of troponin T could be made without 
disrupting the blocked state distribution.  
 The HAHA troponin T construct however, appears to eliminate that fluorescence 
change from the closed state to the blocked state. This corresponds to an elimination of 
the blocked state by the HAHA troponin T construct. Since we showed the terminal 
cysteine present in this construct did not produce any change to the blocked state 
relative to wild type troponin, we can attribute this loss of blocked state to the 
elimination of the basic residues within this region. As was described previously and will 
be expanded on in chapter 5, this assay only gives a relative blocked state value and 





Figure 23: Formation of the inactive B state seen by acrylodan-tropomyosin 
fluorescence. Time courses of acrylodan fluorescence changes for actin regulated by 
wild type (A), 289C (B) and HAHA troponin T (C) following the rapid detachment of 
myosin S1 in the absence of Ca2+ at 10 °C. Traces shown are averages of at least five 
different measurements. The associated amplitudes of the closed to blocked transition 
were 0.28 for both wild type and 289C TnT troponin. The associated apparent rate 
constants were, 32 and 29 per sec for wild type and 289C TnT troponin, respectively. 
No amplitude or rate constant could be determined for HAHA TnT. 2 µM actin, 0.43 µM 
tropomyosin, 0.43 µM troponin and 2 µM S1 in 20 mM MOPS, 152 mM KCl, 4 mM 
MgCl2, 1 mM dithiothreitol and 2 mM EGTA was rapidly mixed with 2 mM ATP, 20 mM 
MOPS, 152 mM KCl, 8 mM MgCl2, 1 mM dithiothreitol and 2 mM EGTA. Acrylodan was 





The acrylodan tropomyosin assay was additionally completed on another mutant, 
S275C troponin T, where serine 275 corresponding with the fourteenth residue from the 
C-terminus was substituted with a cysteine. This mutant was designed for FRET studies 
and we wanted to ensure that mutation did not appreciably affect the blocked state 
population. The S275C mutant behaved identically to wild type troponin T. Figure 24 
shows a summary of the results from the acrylodan experiment incorporating HAHA, 
289C and 275C troponin T troponin as well as wild type and ∆14 troponin T troponin. 
 
 
Figure 24: Ampltidues of acrylodan tropomyosin relative to wild type troponin regulated 




As an additional means of measuring the effect of the HAHA troponin T construct 
on the relative blocked state distribution, we measured the rate of fluorescence change 
of pyrene actin upon binding of myosin S1 with actin in excess at different calcium 
concentrations. This assay takes advantage of the differential rates of binding to each 
state of actin. Because myosin S1 binds the closed and open states more rapidly than 
the blocked state, a lower rate of binding at low calcium indicates a greater population 
of the blocked state. Figure 24 shows the time course of pyrene fluorescence upon 
myosin S1 binding. Curves A and B are for wild type and 289C troponin T troponin 
respectively. The 289C mutant produced a rate of fluorescence change equivalent to 
that of the wild type troponin regulated actin indicating that the additional C-terminal 
cysteine did not affect rate of myosin S1 binding and presumably does not affect the 
blocked state population.  
Curve C is the time course of fluorescence change for actin regulated with HAHA 
troponin T. Actin regulated by this mutant produces a more rapid fluorescence change 
corresponding with a lower initial blocked state population. Because the 289C mutant 
did not produce a rate of this transition that differed from that produced by actin 
regulated with wild type troponin, this observed increase in the rate of the pyrene 
fluorescence change can be attributed to the elimination of the basic residues from the 
C-terminal region of TnT. From this assay, it appears the elimination of those basic 






Figure 25: Rate of binding of S1 to an excess of pyrene labeled actin filaments 
containing tropomyosin and troponin in the absence of ATP at a very low Ca2+ 
concentration. Plots are averages of at least five time courses of binding to actin-
tropomyosin containing wild type (A); 289C (B); and HAHA troponin T (C). Dashed lines 
are single exponential fits. The apparent rate constants were 1.0, 1.2, and 4.1 per 
second for wild type, 289C, and HAHA TnT respectively. At 25 °C, 4 μM pyrene-actin 
(40% labeled), 0.86 μM tropomyosin and 0.86 μM troponin were rapidly mixed with 0.4 
μM myosin S1 in 20 mM MOPS, 152 mM KCl, 4 mM MgCl2, 1 mM dithiothreitol and 2 
mM EGTA. Pyrene was excited using a 360nm LED. The fluorescence was monitored 




We also monitored the fluorescence change of pyrene upon binding of myosin 
S1 to an excess of pyrene actin regulated by wild type, 289C troponin T, and HAHA 
troponin T troponin (Figure 24) at saturating calcium concentrations. By the 
assumptions made in the equations described previously (Equations 6-8), the saturating 
calcium rate should be a constant and is necessary for calculating the low calcium actin 
state distribution by this method. There was minimal difference in the rate of 
fluorescence change for wild type (1/sec) and 289C (1.2/sec) troponin T troponin 
regulated actin showing again that the introduction of the terminal Cys residue did not 
affect function. However, HAHA troponin T produced a more rapid rate of binding similar 
to that observed earlier for ∆14 troponin T in Figure 25. Under these conditions, HAHA 
troponin T stabilized the active O state. Contrary to the assumptions made in Equation 




Figure 26: Rate of binding of S1 to an excess of pyrene labeled actin filaments 
containing tropomyosin and troponin in the absence of ATP at a saturating Ca2+ 
concentration. Plots are averages of at least five time courses of binding to actin-
tropomyosin containing wild type (A); 289C (B); and HAHA troponin T (C). Dashed lines 
are single exponential fits. The apparent rate constants were 3.7, 3.9, and 6.8 per 
second for wild type, 289C, and HAHA TnT respectively. At 25 °C, 4 μM pyrene-actin 
(40% labeled), 0.86 μM tropomyosin and 0.86 μM troponin was rapidly mixed with 0.4 
μM myosin S1 in 20 mM MOPS, 152 mM KCl, 4 mM MgCl2, 1 mM dithiothreitol and 0.2 
mM CaCl2. Pyrene was excited using a 360nm LED. The fluorescence was monitored 




Part 4: At saturating Ca2+ concentration HAHA troponin T behaves similarly to ∆14 
troponin T  
 The high alanine high activity (HAHA) troponin T construct appears to 
significantly diminish or eliminate the blocked state to an equivalent extent as ∆14 
troponin T at very low calcium concentrations. We also wanted to identify if this HAHA 
troponin T construct stabilized the open O state at saturating calcium concentrations. 
We measured the ATPase rates of unregulated, wild type, 275C, 289C, and HAHA 
troponin T to determine the extent to which each stabilizes the active O state (Figure 
24). Wild type, 275C, and 289C troponin T troponin each produced an ATPase rate of 
about 2 per second. The additional cysteine at the C-terminus or the cysteine 
substitution at residue 275 did not appreciably disrupt the open O state distribution 
relative to wild type troponin regulated actin.  
 The HAHA troponin T construct, on the other hand, increased the ATPase rate to 
3.9 per second. This doubling of the ATPase rate relative to wild type troponin regulated 
actin is what was previously observed with Δ14 troponin T regulated actin. It appears 
from this assay that the HAHA troponin T construct stabilizes the O state to a similar 
extent as the Δ14 troponin T mutant. Because the 289C mutant did not appreciably 
affect the O state, this increase in O state population by HAHA troponin T can be 
attributed to substitution of the seven basic residues within the 16 C-terminal residues. 
By each of our measures of quantifying the actin state distribution, the HAHA troponin T 





Figure 27: ATPase rates of myosin S1 in the presence of actin and actin-tropomyosin 
containing troponin with different mutants of troponin T at saturating Ca2+. 
Measurements were made at 25o C and pH 7.0 in solutions containing 1 mM ATP, 4 mM 
MgCl2, 31 mM KCl, 10 mM MOPS, 1 mM dithiothreitol and 0.1 mM CaCl2. The 





Part 5: A8V∆14 troponin T affects Km but not Vmax 
 Our lab observed that troponin containing ∆14 troponin T or A8V∆14 troponin47,78 
substantially increased the open state population. This observation was made at an 
actin concentration well below the KM and the rates were proportional to Vmax/KM. We 
studied the rates at increasing actin concentrations to determine if the increase in rate 
was due to an increase in Vmax or a decrease in KM. The importance of this distinction 
will be discussed in Chapter 5 
We repeated the ATPase assay of unregulated actin and actin regulated by 
A8V∆14 at a variety of actin concentrations. We chose to use A8V∆14 in these 
experiments because this mutant produces the highest ATPase rate by a troponin 
mutant thus far observed. We used actin concentrations ranging from 10 to 400 µM for 
unregulated actin and 5 to 150 µM for actin regulated by A8V∆14 Tn. 
 Figure 28 shows a plot of the ATPase rate versus the actin concentration for 
unregulated actin (circles) and actin regulated by A8V∆14 (squares). At 10 µM actin, the 
rate was about three times that of unregulated actin. The rate at this concentration 
corresponds to the conditions used in our previously described ATPase assays (Figure 
21). As the actin concentration increased, stimulation of the myosin ATPase rate 





Figure 28: ATPase rates of myosin S1 in the presence of unregulated actin (circles) and 
actin regulated with tropomyosin and A8V∆14 troponin at saturating Ca2+. 
Measurements were made at 25o C and pH 7.0 in solutions containing 1 mM ATP, 4 mM 
MgCl2, 31 mM KCl, 10 mM MOPS, 1 mM dithiothreitol and 0.1 mM CaCl2. The 
concentrations of S1 was 0.1 µM. The actin concentration was varied. Tropmyosin and 
troponin were maintained in a 7:1.1 ratio relative to actin. The Vmax was 35 (±4) and 35 
(±8) /second for unregulated actin and A8V∆14 regulated actin respectively. The KM 





 The Vmax was 35 (±4) and 35 (±8) /second for unregulated actin and A8V∆14 
regulated actin respectively. There was no appreciable change in the Vmax. The KM 
was 258 (±49) and 90 (±36) for unregulated actin and A8V∆14 regulated actin 
respectively. From these results, it appears that the activating quality of A8V∆14 is 
primarily the result of a decrease in the KM. The implications of these results and the 
significance of a troponin construct that can stabilize the open state will be described in 
Chapter 5. 
 
Chapter 4: Dynamics of the C-Terminus of Troponin T and structural 
consequence of mutation 
Part 1: Using FRET to map the location of the C-terminus of troponin T. 
The previous chapter (Chapter 3) focused on the functional consequence of 
mutation within the C-terminal 16 residues of troponin T. In that chapter, we established 
that truncation from the C-terminus results in a graded elimination of the blocked state 
at low calcium concentrations and stabilization of the open O state at saturating calcium 
concentrations. We generated a construct, HAHA (high alanine, high activity) troponin T 
to assess the importance of the positive charges on the function of the C-terminus of 
troponin T. Analysis of that construct revealed elimination of those basic residues 
corresponded with loss of the blocked state at low calcium concentrations and 
stabilization of the open O state at saturating calcium concentrations. This HAHA 
troponin T construct exhibited functional properties that were by our measures, 
equivalent to the properties of the ∆14 troponin T mutant observed previously. 
This chapter focuses on the structural properties of the C-terminus of troponin T 
in an attempt to elucidate the structural basis for the functions of the C-terminus of 
troponin T. The interactions required for the C-terminus function are fundamental to our 
basic understanding of regulation by troponin. These interactions present novel targets 
for sarcomeric modulators to affect the distribution between actin states. Modulators 
that specifically inhibit or enhance these interactions may allow fine tuning of actin 
states to restore normal contractile activity in those with cardiovascular diseases. 
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 To investigate the interactions of the C-terminus, we designed a series of 
fluorescence resonance energy transfer (FRET) experiments to measure the efficiency 
of transfer between probes on the C-terminus of troponin T and other locations within 
the thin filament. These measures of transfer efficiency indicate the closeness between 
the probed locations. Each measurement was conducted at both a very low calcium 
concentration and at saturating calcium to identify the structural response of each 
probed pair to changes in activation status. Additionally, we can convert these 
efficiencies to absolute distances using additional parameters. Along with the distances 
obtained from other labs, our acquired distances will ultimately be used as constraints in 
molecular modelling simulations. The goal of which is to map the location of the C-
terminus into a model of the actin-tropomyosin-troponin complex.  
We designed each FRET measurement to strategically answer a targeted 
question (Table 5). We ultimately plan to incorporate these measurements as 




Table 5: Summary of justifications for each FRET measurement.  
Donor Acceptor Justification 
TnT 275C C374 of actin Identify possible interaction of highly basic TnT C-
terminus to the highly negatively charged surface of 
actin 
TnT 289C C374 of actin Identify possible interaction of highly basic TnT C-




C374 of actin Identify possible disruption of interaction of TnT C-
terminus and highly negatively charged surface of 
actin resulting from elimination of basic residues in C-
terminus 
TnI T143C C374 of actin Develop a FRET sensor to measure the known 




C374 of actin Identify disruption to the inhibitory peptide binding 
actin resulting from the activating mutant, ∆14 TnT 
TnT 275C C190 of Tpm Test external evidence that these two regions interact 
or bind 




C190 of Tpm Identify possible disruption of interaction of TnT-C 
terminus and Tpm resulting from elimination of basic 
residues in C-terminus 
TnI T143C C190 of Tpm Approximate distance between inhibitory peptide 
binding site on actin and Tpm as very low calcium 
concentration. Approximate distance between TnI 




C190 of Tpm Identify disruption to this distance resulting from 
activating construct, ∆14 TnT 
TnT 275C 143C of TnI Identify how the inhibitory region of TnI and C-
terminus of TnT emerge from the IT helix. 
Approximate closeness of 275C TnT to inhibitory 
region binding site of actin at very low calcium 
concentrations. Approximate closeness of 275C TnT 
to TnI inhibitory region binding site of TnC at 
saturating calcium. 
TnT 289C 143C of TnI Approximate distance between 275C and 289C TnT. 
Approximate closeness of 289C TnT to inhibitory 
region binding site of actin at very low calcium 
concentrations. Approximate closeness of 289C TnT 





 We developed the troponin T constructs 289C and S275C to attach fluorescent 
probes in our FRET experiments. For each of these constructs, the added cysteine is 
the only cysteine available for labelling. The 289C construct is the wild type troponin T 
sequence with an additional cysteine appended to the C-terminus. The S275C construct 
is the wild type troponin T sequence with residue S275 substituted with a cysteine. The 
effect of those modifications on our measures of the blocked and open O state were 
measured and described in the previous chapter (Chapter 3). We found that both 289C 
and S275C are statistically equivalent to wild type troponin by each of our measures of 
the actin state distribution at very low and saturating calcium. 
 Those two locations on the C-terminus of troponin T, 275 and 289, compose the 
boundaries of the C-terminus that we are interested in mapping into a model of actin-
tropomyosin-troponin. Residue 289 is at the far C-terminus and residue 275 is fourteen 
residues from the C-terminus, corresponding with the ∆14 mutation. Ideally, efficiency 
measurements at both locations will allow us to better triangulate the exact position and 
orientation of the C-terminus relative to other locations within actin-tropomyosin-
troponin. 
 We also targeted the HAHA troponin T construct with a fluorescent probe. Recall 
that mutant has the seven basic residues of the C-terminus substituted with alanine and 
an additional cysteine appended to the C-terminus at 289C. Measurements with HAHA 
troponin T will be most directly comparable to those made with 289C troponin T as the 
probe for each is at the 289 position. These efficiency measurements are important for 
identifying the position of the C-terminus when actin is stabilized almost entirely in the O 
state at saturating calcium and when the blocked state is virtually absent at very low 
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calcium concentrations. This will assist us in better understanding the conformation of 
actin-tropomyosin-troponin when fully activated.  
 A T143C troponin I construct was developed for a variety of reasons. Residue 
143 of troponin I is within the well characterized inhibitory region of troponin I that is in 
known to interact with actin at very low calcium concentrations and troponin C at 
saturating calcium concentrations. The relative location of T143C can be seen in (Figure 
14). Because the inhibitory region of troponin I is known to interact with actin at low 
calcium concentrations, we propose that measuring the efficiency of transfer between 
the C-terminus of troponin T and the inhibitory region of troponin I at low calcium 
concentrations is a method of approximating the efficiency of transfer between the C-
terminus of troponin T and that corresponding inhibitory region of actin. This will provide 
some insight into our hypothesis that the C-terminus of troponin T might interact with 
actin similarly to the inhibitory region of troponin I.  
 Because the inhibitory region of troponin I is known to interact with troponin C at 
saturating calcium, we propose that measuring the efficiency of transfer between the C-
terminus of troponin T and the inhibitory region of troponin I at saturating calcium is a 
method of approximating the efficiency of transfer between the C-terminus of troponin T 
and the inhibitory peptide binding location on troponin C. This will provide some insight 
into our hypothesis that the C-terminus of troponin T might interact with the hydrophobic 
pocket of troponin C similarly to the inhibitory peptide.  
The inhibitory peptide of troponin I and the C-terminus of troponin T are both 
immediately adjacent to the IT helix and are known to be in relatively close proximity, at 
least at the N-terminus of each domain. Based on the sequence alignment of troponin I 
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and troponin T composing the IT helix, residues T143 of troponin I and S275 of troponin 
T must be in relatively close proximity. Measuring the transfer efficiency between those 
two locations will resolve how those two domains emerge from the IT helix.  
 Because it is known that S275 of troponin T is relatively close to T143, we 
propose that the transfer efficiency between T143C and 289C is an approximation of 
the transfer efficiency that would be measured between 275C and 289C. This 
measurement allows us to determine whether the C-terminus of troponin T adopts a 
relatively compact or expanded structure based on the approximate distance from each 
end of the C-terminal domain. This strategy was designed to circumvent the inability to 
attach a donor and acceptor probe within the same protein to measure an inter-troponin 
T distance. 
In addition to the T143C construct, we also developed a T143C troponin I – ∆14 
troponin T construct where T143C troponin I was reconstituted with wild type troponin C 
and ∆14 troponin T. The idea here was to identify how the activating ∆14 troponin T 
construct affected the efficiency of transfer between the inhibitory region of troponin I 
and other locations within actin-tropomyosin-troponin. This was designed in hopes of 
identifying a structure-function relationship resulting from mutation in the C-terminus of 
troponin T. 
Actin contains two native cysteine residues. One of the cysteines can be 
selectively targeted with fluorescent probes while leaving the other unaffected. This 
actin cysteine, C374, was labelled with a FRET acceptor probe. The efficiency of 
transfer was measured between actin C374 and each of the probed troponin T and 
troponin I constructs.  
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One limitation of the use of actin as an acceptor is that it is possible that multiple 
actin monomers are within range of accepting energy transfer from the donor on 
troponin. Our analysis of this data assumes that only one actin is available for accepting 
the energy transfer. In future molecular modelling simulations, we will be able to 
account for the possibility of multiple acceptors. 
Tropomyosin contains one native cysteine at position 190. The efficiency of 
transfer was measured between tropomyosin C190 and each of the probed troponin T 
and troponin I constructs as well. There is also a limitation to having an acceptor probe 
on tropomyosin. Because tropomyosin is a dimer and each subunit has a cysteine at 
position 190, both subunits can be labelled with a probe. This introduces a variety of 
combinations of labelling on each tropomyosin. Tropomyosin can be unlabeled, labelled 
on one of two subunits or labelled on both subunits. Our analysis of the data assumes 
the location of the acceptor probe on tropomyosin as being one location.  
 Each of the troponin constructs were labeled with an IAEDANS probe to function 
as a donor in the FRET experiments. Actin and tropomyosin were labeled with a 
nonfluorescent DABMI probe to function as an acceptor in FRET experiments. The 
troponin I construct was additionally targeted with the acceptor probe DABMI for inter-
troponin distances between troponin T and troponin I. 
 It is expected that labelling these proteins with bulky fluorescent groups would 
disrupt their ability to maintain the normal actin state distribution to some extent. To 
make valid conclusions from our FRET data, we must determine the extent to which the 
probes affect the proteins function. Ideally, the actin state distribution will not be 
appreciably disrupted by mutation.  
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 We performed ATPase measurements on each of the constructs used in our 
FRET experiments to determine any disruption to their regulatory properties resulting 
from attachment of a bulky fluorescent group. These data are shown in Figure 24. The 
DABMI probe on actin slightly inhibited the unregulated actin stimulation of myosin 
ATPase activity. We proceeded in our FRET experiments with each of these constructs 
as we determined that they either regulate sufficiently or exhibit disruption to activity that 





Figure 29: ATPase rates of myosin S1 in the presence of actin and actin-tropomyosin 
containing troponin with different mutants of troponin T at saturating Ca2+. 
Measurements were made at 25o C and pH 7.0 in solutions containing 1 mM ATP, 4 mM 
MgCl2, 31 mM KCl, 10 mM MOPS, 1 mM dithiothreitol and 0.1 mM CaCl2. The 






 The FRET measurements were completed as described previously in chapter 2. 
The data from our FRET experiments are divided into three tables based on the 
acceptor probe location. These data will be described in more detail in chapter 5. Table 
6 shows the data for our FRET experiments where DABMI C374 of actin is the 
acceptor.  
A particularly interesting result was that the transfer of the troponin I T143C – 
DABMI actin FRET pair was dependent on the absence and presence of ∆14 troponin 
T. This pair appears to be a direct measure of the binding of the inhibitory region of 
troponin I to actin which is a characteristic mechanism of calcium regulation and 
presents a new method for measuring mutation effects on regulation. In the presence of 
∆14 troponin T, the efficiency between that pair decreased at both low and saturating 
calcium. This suggested ∆14 troponin T disrupted that interaction between the inhibitory 
region of troponin I and actin. We looked further into this pair and describe the results in 
part 3 of this chapter. 
Table 6 shows the data for our FRET experiments where DABMI C190 of 
tropomyosin is the acceptor. We observed a particularly high transfer efficiency between 
IAEDANS 275C troponin T and DABMI C190 tropomyosin. Though the efficiency at 
saturating calcium was not high enough to explicitly suggest those locations interact, it 
is possible a nearby location of both regions may interact. This is supported by evidence 
of other labs that suggest the C-terminus of troponin T interacts with tropomyosin near 
C190 of tropomyosin. That pair also exhibited an appreciable decrease in efficiency at 
saturating calcium suggesting the regions move further apart or possibly dissociate. The 
high resolution crystal structure of troponin modeled onto the actin crystal structure48 at 
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low and saturating calcium concentrations showed a similar calcium response of these 
two regions relative to one another. The next section of this chapter will focus on the 
FRET pairs monitoring distances between troponin and DABMI C190 tropomyosin.  
Table 6 shows the data for our FRET experiments where DABMI T143C of 
troponin I is the acceptor. Although the efficiency of transfer is high, the distance 
between T143C and S275C was greater than that expected based on the sequence 
alignment emerging from the IT-Helix69. The implications of this result will be discussed 
in Chapter 5. 









IAEDANS TnT 275C 0.24 .13 48 55 
IAEDANS TnT 289C 0.11 .09 56 58 
IAEDANS HAHA TnT 289C 0.05 .06 65 63 
IAEDANS TnI T143C 0.25 .09 48 58 
IAEDANS TnI T143C Δ14 TnT 0.20 .04 50 68 
 









IAEDANS TnT 275C 0.86 (.04) .55 (.10) 30 39 
IAEDANS TnT 289C 0.70 (.07) .51 (.02) 35 40 
IAEDANS HAHA TnT 289C 0.53 (.01) .35 (.01) 39 44 
IAEDANS TnI T143C 0.73 (.02) .48 (.02) 34 40 
IAEDANS TnI T143C Δ14 TnT 0.38 (.01) .25 (.01) 43 48 
 









IAEDANS TnT 275C 0.60 (0.02) .65 (0.02) 37 36 




Part 2: Time course of FRET upon deactivation of regulated actin 
With the FRET measurements described above, we developed a general idea of 
the location of the C-terminus of troponin T relative to other locations within the actin-
tropomyosin-troponin complex. The most likely interaction of the C-terminus of troponin 
T at saturating calcium is with tropomyosin near C190. As well, we showed a calcium 
response for some of the distances suggesting the mechanism of regulation. The 
distance between the C-terminus of troponin T and tropomyosin C190 increased with 
calcium indicating the C-terminus takes on an extended conformation or dissociates.  
A series of rearrangements occur upon calcium binding to troponin C causing a 
repositioning of tropomyosin. Though we do not yet know all of these rearrangements, 
at minimum, they include opening of a hydrophobic pocket of troponin C and a resultant 
enhanced association of troponin I with troponin C. Another step toward understanding 
the mechanism of the C-terminus function is to determine which rearrangements in the 
troponin calcium response is affected by the C-terminus of troponin T. The C-terminus 
of troponin T must be involved in one or more of the steps in that series or directly 
influence one or more of those steps. The previous FRET studies help to define 
interacting partners. Time courses of FRET help to define where in time the changes in 
troponin T occur in the sequence. This work presents some of the first steps taken to 
achieve that goal. 
We wanted to identify a FRET pair involving the C-terminus of troponin T that 
had a high transfer efficiency and a dependence on calcium concentration. This was in 
the interest of finding a reliable FRET pair whose efficiency change could be monitored 
in the time course of our kinetic assays. This would allow us to identify if the C-terminus 
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is required for a transition, if the C-terminus is dependent on that transition, or if the C-
terminus is coupled to that transition.  
The acrylodan ATPchase assay measured the redistribution of actin from the 
fully active open state to a distribution of the closed and blocked states (Figure 13). 
Based on past results from the acrylodan fluorescence time course of that assay at 10° 
C, actin is primarily in the closed state at 0.1 seconds. At 0.5 seconds, actin is 
equilibrated between the closed and blocked states when wild type troponin is 
regulating actin. The troponin mutants 289C and 275C troponin T did not appreciably 
affect the state distribution. The HAHA troponin T mutant eliminated the fluorescence 
transition attributed to the blocked state. 
We measured the efficiency of the IAEDANS troponin – DABMI C190 
tropomyosin FRET pairs over the time course of that same reaction. The FRET pairs 
between troponin and DABMI tropomyosin exhibited a high transfer efficiency and a 
notable change in efficiency with change in calcium concentration. This allowed us to 
measure how different regions of troponin move relative to tropomyosin as actin 
redistributes from the open state into the closed and blocked states.  
Figure 24 shows the results of the S1 dissociation experiment following the 
fluorescence of IAEDANS 289C troponin T with and without the acceptor probe DABMI 
on C190 tropomyosin. Plot A shows the fluorescence time course of donor IAEDANS in 
the absence of acceptor DABMI at 10° C. That trace remains relatively constant over 
the normal time course of the reaction. Plot B shows the fluorescence time course of 
donor IAEDANS in the presence of acceptor DABMI at 10° C. This plot is shifted 
downwards indicating quenching of IAEDANS fluorescence by the DABMI acceptor 
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probe. A decrease in fluorescence is observed over the course of the reaction. This 
decrease in the IAEDANS is the result of an increase in fluorescence quenching by the 
DABMI acceptor.  
These traces were replotted as efficiency versus time by converting the 
fluorescence plots to efficiency using the equation 1-(DA/D) where DA is the 
fluorescence time course when the acceptor is present, and D is the fluorescence time 
course when the acceptor is absent. Plot G shows the resulting plot of efficiency versus 
time for IAEDANS 289C troponin T transfer to DABMI C190 tropomyosin as S1 is 
dissociated from actin at 10° C. These plots show the efficiency before it has been 
corrected for the extent of labelling on the acceptor probe. The increase in efficiency 
means that the IAEDANS and DABMI probes moved closer to each other throughout 
the time course of the reaction. This experiment was repeated at both 18° C and 25° C. 
An Arrhenius plot of the temperature dependence is shown in Appendix C: 
Supplementary Data. The linearity of the plot shows that the rate limiting step is not 
affected by the temperature.  
The initial and final efficiency of the IAEDANS 289C troponin T - DABMI C190 
tropomyosin FRET pair at 10° C was 0.29 and 0.46, respectively. The efficiencies and 
distances from this experiment are summarized in Table 9. We attribute the initial 
efficiency value of 0.29 to the transfer between IAEDANS 289C troponin T and DABMI 
C190 tropomyosin when actin is stabilized fully in the closed state. 
The final efficiency is a measure of the efficiency of transfer when actin has 
equilibrated between the closed and blocked states. That distribution is dependent on 
the troponin construct that is regulating actin. As described previously, we question the 
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validity of the methods available to estimate the blocked state population at low calcium 
concentrations, however, we previously published a value of 87% blocked state for wild 
type troponin regulated actin at low calcium concentrations as determined by the pyrene 
method78. Therefore, the final efficiency value 0.46 corresponds to the efficiency of 
transfer between IAEDANS 275C troponin T and DABMI C190 of tropomyosin when 
actin is approximately 87% in the blocked state.  
From these efficiencies, we calculated the distances to be 46 and 41 Å for the 
initial and final distance, respectively. These values follow the same trend that was 
observed in the steady state FRET measurements between IAEDANS 289C troponin T 
and DABMI C190 of tropomyosin. In both cases, 289C of troponin T is closer to C190 of 





Figure 30: Time courses of IAEDANS 289C TnT fluorescence change in the absence 
and presence of a DABMI fluorescence acceptor probe on C190 of tropomyosin 
following the rapid detachment of myosin S1 from actin at very low Ca2+ concentrations. 
Traces shown are averages of at least three different measurements. Traces A, C and 
E are in the absence of acceptor DABMI. Traces B, D and F are in the presence of 
acceptor DABMI. Traces G, H, and I are the efficiency of transfer between IAEDANS 
and DABMI. 2 µM actin, 0.51 µM tropomyosin, 0.43 µM troponin and 2 µM S1 in 20 mM 
MOPS, 152 mM KCl, 4 mM MgCl2, 1 mM dithiothreitol and 2 mM EGTA was rapidly 
mixed with 2 mM ATP, 20 mM MOPS, 152 mM KCl, 8 mM MgCl2, 1 mM dithiothreitol 
and 2 mM EGTA at 25° C. IAEDANS was excited using a 340nm LED and the 
fluorescence monitored through a 435/451/460 filter. Apparent rates: G, 7.0(±0.1); H, 
13.7(±0.3); I, 25(±1).  
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 One of the primary goals of these structural measurements was to determine 
how mutation in the C-terminus of troponin T affects the structural response of the 
region. We monitored the fluorescence time course of IAEDANS HAHA 289C troponin T 
as myosin S1 dissociated from actin in the absence (Figure 24A) and presence (Figure 
24B) of DABMI C190 tropomyosin. The resultant efficiency change from that pair is 
plotted in Figure 24C. This pair is analogous to that shown in Figure 24 above with the 
exception that this pair contains the HAHA troponin T sequence which enhances activity 
by stabilizing the O state at saturating calcium and eliminating the B state at very low 
calcium.  
We did not observe an appreciable change in efficiency over the course of this 
reaction. The efficiency of the IAEDANS HAHA 289C troponin T - DABMI C190 
tropomyosin FRET pair at 18° C over the course of the reaction was 0.34. This 
corresponds to a distance of 45 Å. Because HAHA troponin T is present in this pair, 
actin is stabilized nearly 100% in the closed state following dissociation of myosin S1 at 
a low calcium concentration. As we expected, no change in efficiency is observed as 





Figure 31: Time courses of IAEDANS HAHA 289C TnT fluorescence change in the 
absence and presence of a DABMI fluorescence acceptor probe on C190 of 
tropomyosin following the rapid detachment of myosin S1 from actin at very low Ca2+ 
concentrations. Traces shown are averages of at least three different measurements. 
Trace A, donor alone; B, donor and acceptor; C, efficiency. 2 µM actin, 0.51 µM 
tropomyosin, 0.43 µM troponin and 2 µM S1 in 20 mM MOPS, 152 mM KCl, 4 mM 
MgCl2, 1 mM dithiothreitol and 2 mM EGTA was rapidly mixed with 2 mM ATP, 20 mM 
MOPS, 152 mM KCl, 8 mM MgCl2, 1 mM dithiothreitol and 2 mM EGTA at 25° C. 




The fluorescence of IAEDANS 275C troponin T was followed as myosin S1 
dissociated from actin in the absence and presence of the DABMI acceptor probe on 
tropomyosin (Figure 24). In the absence of acceptor, the fluorescence of this probe 
remains relatively constant throughout the time course of this reaction (Figure 24A). In 
the presence of acceptor, the IAEDANS fluorescence decreased throughout the time 
course of the reaction (Figure 24B). The efficiencies were replotted using the equation 
described above (Figure 24C).  
The initial and final efficiency of the IAEDANS 275C troponin T - DABMI C190 
tropomyosin FRET pair was 0.66 and 0.74 respectively. The efficiencies and distances 
from this experiment are summarized in Table 9. We attribute the initial efficiency value 
of 0.66 to the transfer between IAEDANS 275C troponin T and DABMI C190 
tropomyosin when actin is stabilized fully in the closed state. We attribute the final 
efficiency value 0.74 to the efficiency of transfer between IAEDANS 275C troponin T 
and DABMI C190 of tropomyosin when actin is approximately 87% in the blocked state.  
From these efficiencies, we calculated the distances to be 36 and 34 Å for the 
initial and final distance respectively. These values follow the same trend that was 
observed in the steady state FRET measurements between IAEDANS 275C troponin T 
and DABMI C190 of tropomyosin. In both cases 275C of troponin T is closer to C190 of 





Figure 32: Time courses of IAEDANS 275C TnT fluorescence change in the absence 
and presence of a DABMI fluorescence acceptor probe on C190 of tropomyosin 
following the rapid detachment of myosin S1 from actin at very low Ca2+ concentrations. 
Traces shown are averages of at least three different measurements. Apparent rate: 
3.4/second. Trace A, donor alone; B, donor and acceptor; C, efficiency. 2 µM actin, 0.51 
µM tropomyosin, 0.43 µM troponin and 2 µM S1 in 20 mM MOPS, 152 mM KCl, 4 mM 
MgCl2, 1 mM dithiothreitol and 2 mM EGTA was rapidly mixed with 2 mM ATP, 20 mM 
MOPS, 152 mM KCl, 8 mM MgCl2, 1 mM dithiothreitol and 2 mM EGTA at 25° C. 





 We additionally monitored the fluorescence change of IAEDANS T143C troponin 
I as myosin S1 dissociated from actin in the absence (Figure 24A) and presence (Figure 
24B) of an acceptor DABMI probe on tropomyosin. Since the locations of this inhbitory 
region of troponin I are well characterized, this experiment additionally measures the 
distance between tropomyosin and those known locations as actin is deactivated. As 
shown previously, these traces were replotted as efficiency versus time (Figure 24C). 
The efficiency of this pair also increased over the time course of the reaction. This 
indicates that IAEDANS T143C troponin I moves closer to DABMI C190 of tropomyosin 




Figure 33: Time courses of IAEDANS T143C TnI fluorescence change in the absence 
and presence of a DABMI fluorescence acceptor probe on C190 of tropomyosin 
following the rapid detachment of myosin S1 from actin at very low Ca2+ concentrations. 
Traces shown are averages of at least three different measurements. Apparent rate: 
8.9/second. Trace A, donor alone; B, donor and acceptor; C, efficiency. 2 µM actin, 0.51 
µM tropomyosin, 0.43 µM troponin and 2 µM S1 in 20 mM MOPS, 152 mM KCl, 4 mM 
MgCl2, 1 mM dithiothreitol and 2 mM EGTA was rapidly mixed with 2 mM ATP, 20 mM 
MOPS, 152 mM KCl, 8 mM MgCl2, 1 mM dithiothreitol and 2 mM EGTA at 25° C. 
IAEDANS was excited using a 340nm LED and the fluorescence monitored through a 
435/451/460 filter.  
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Table 9: Efficiency of transfer, distances and rates of FRET from IAEDANS to DABMI 












275C 10° C 
0.66 0.74 36 34 3.4(±0.1) 
IAEDANS TnT 
289C 10° C 
0.29 0.46 46 41 7.0(±0.1) 
IAEDANS TnT 
289C 18° C 
0.35 0.47 44 41 13.7(±0.3) 
IAEDANS TnT 
289C 25° C 
0.41 0.49 42 40 25(±1) 
IAEDANS 
HAHA TnT 
289C 18° C 
0.34 0.34 45 45 NA 
IAEDANS TnI 
T143C 10° C 
0.26 0.34 47 45 8.9(±0.2) 
*Typical rate of acrylodan fluorescence transition is 7/second for wild type troponin 





Part 3: Mutation in C-terminus of troponin T is coupled to Troponin I – Actin 
interaction. A structure-function relationship. 
 We found from our FRET measurement between IAEDANS T143C troponin I and 
DABMI C374 of actin, that the efficiency of transfer decreased with increasing calcium 
concentration. This indicated that the inhibitory region of troponin I was further from 
C374 of actin when the calcium concentration was higher. The location of that donor 
probe, T143C, is in the well characterized inhibitory region of troponin I that is known to 
interact with actin at low calcium concentrations and troponin C at saturating calcium 
concentrations. This is the result that we expected from this experiment as we observed 
the inhibitory region of troponin I apparently dissociating from actin. We had now 
developed a FRET sensor that could apparently directly monitor the binding of the 
inhibitory region of troponin I to actin. 
 We utilized this FRET sensor to monitor how mutation within the C-terminus of 
troponin T effects the interaction between the inhibitory region of troponin I and actin. 
We reconstituted IAEDANS T143C troponin I with ∆14 troponin T and wild type troponin 
C. We measured the FRET sensor at very low and saturating calcium in the absence 
and presence of the activating ∆14 troponin T mutant. At a very low calcium 
concentration, the FRET transfer efficiency was markedly lower for ∆14 troponin T 
regulated actin than that obtained when actin was regulated with wild type troponin T. 
This suggests that the inhibitory region of troponin I had weaker binding to actin or was 
bound differently so that the probes were further away when the C-terminal region of 
troponin T was missing.  
At saturating calcium concentrations, the efficiency of transfer was also lower for 
∆14 troponin T than for wild type troponin T regulated actin. In the wild type case, the 
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troponin I inhibitory region distance to actin increased as expected since the inhibitory 
region is known to dissociate from actin at saturating calcium. In the case of the ∆14 
troponin T mutant, the distance from actin is even greater. One explanation is that at 
saturating calcium, the binding target for the C-terminus of troponin T is either different 
or in an altered position. That change is the key to understanding how removing the last 
fourteen residues of troponin T leads to activation.  
 We performed a calcium titration of this FRET sensor monitoring the inhibitory 
region of troponin I binding to actin. One purpose of this experiment was to determine if 
this FRET sensor functioned over the physiological calcium concentrations associated 
with calcium regulation. Additionally, by performing this titration we could determine if 
the ∆14 troponin T mutant affects the pCa50 or the hill coefficient of this FRET sensors 
calcium response.  
We used a Ca-EGTA buffer to prepare the FRET sensor solutions at a variety of 
calcium concentrations with either wild type troponin T or ∆14 troponin T (Appendix C: 
Supplementary Data). After initial FRET measurements, the results were plotted to 
identify the necessary calcium concentrations for the solutions needed to obtain an 





Figure 34: Calcium dependence of IAEDANS T143C TnI– DABMI C374 FRET pair in 
the absence (closed circles) and presence (open circles) of ∆14 TnT. Conditions of 
FRET measurements: 2 µM actin, 0.51 µM tropomyosin, 0.43 µM troponin in 20 mM 
MOPS, 152 mM KCl, 4 mM MgCl2, 1 mM dithiothreitol and mixture of Ca2+-EGTA buffer, 
Ca2+ and EGTA to reach desired pCa at 25° C. Excitation at 336 nm. Fluorescence 
integrated from 460-600nm. Slit widths were 3nm. 
 
This plot shows the IAEDANS T143C troponin I – DABMI C374 actin efficiency 
versus the calcium concentration with wild type (closed circles, A) or ∆14 troponin T 
(open circles, B) troponin. The curve overlayed on each set of data is a fit to the Hill 
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equation. This fit gave a hill coefficient of 16.1 and 15.7 for wild type and ∆14 troponin T 
respectively. This indicated that the slope of the change in efficiency was lower in the 
∆14 troponin T case. The movement of T143C troponin I relative to actin was less 
cooperative in the ∆14 troponin T case.  
The pCa50 was 4.4 and 4.3 for wild type and ∆14 troponin T respectively. This 
indicated that the FRET sensor was less sensitive to calcium in the ∆14 troponin T 
case. A higher calcium concentration was required for movement of T143C troponin I 
relative to actin when ∆14 troponin T was present. 
Part 4: ∆16 troponin T peptide in Myosin ATPase Assay 
 We purified a Troponin T peptide consisting of the last sixteen residues of the C-
terminus of troponin T. The idea was to determine if this peptide could act as a small 
molecule modulator of the actin state distribution. We predicted this region would bind in 
a similar manner to the C-terminus of troponin T and either enhance the functional 
outcome of the C-terminus or compete for binding with the C-terminus and inhibition 
function. 
 We incorporated the peptide at varying concentrations into the myosin ATPase 
assay under the same conditions performed previously in Figure 21 in the presence of 
unregulated actin. Those results are shown in Figure 35. We found that as the peptide 
concentration was increased, the myosin ATPase rate decreased. This suggested that 
the peptide was binding to actin in such a way that inhibited actin stimulation of myosin 




Figure 35: ATPase rates of myosin S1 in the presence of actin and different 
concentrations of the ∆16 troponin T peptide. Measurements were made at 25o C and 
pH 7.0 in solutions containing 1 mM ATP, 3 mM MgCl2, 34 mM NaCl, 10 mM MOPS, 1 
mM dithiothreitol and 0.1 mM CaCl2. The concentrations of S1 and actin were 0.1 and 
10 µM, respectively. 
 
However, we noticed what appeared to be some precipitation in our reaction 
mixtures. A spin down assay was used to determine if this was in fact precipitation and 
if the precipitation correlated with the concentration of peptide added. The reaction 
mixtures were made as they were in the myosin ATPase assay experiment but 
excluding 32P ATP and myosin S1. After thirty minutes, the mixtures were spun at 
20,000 RPM in a rotor for 30 minutes in a Sorvall Legend Micro 21R centrifuge. The 
supernatant was carefully removed and 20 µL water was added to each tube. An SDS-
PAGE gel was run for each of those samples. This gel revealed that as the peptide 
concentration was increased, a greater amount of actin was precipitated. The gel is 
shown in Appendix C: Supplementary Data.
 
Chapter 5 Discussion 
Previous data from our lab demonstrated that the cardiomyopathy mutation ∆14 
troponin T, missing fourteen residues from the C-terminus, produces marked changes in 
ATPase activity, binding of myosin S1 to actin, conformational changes associated with 
regulatory status, and contraction of muscle fibers. Those observations showed that 
14 troponin T eliminated or substantially diminished the blocked state at very low 
calcium concentrations and stabilized the open O state at saturating calcium 
concentrations. These effects are presumably a result of changes to the interactions 
among the components of the regulatory complex of actin, tropomyosin and troponin. 
One goal of this project was to identify the specific residues within the C-terminus of 
troponin T that modify these interactions. The second primary goal of this project was to 
identify the interactions normally maintained by the C-terminus of troponin T and how 
those interactions are changed by mutation. 
 
Stepwise elimination of C-terminus eliminates the blocked state in a graded 
manner 
To identify the relative importance of each residue within the C-terminus, we 
developed and characterized a series of truncation mutants of troponin T. That 
truncation series included ∆4, ∆6, ∆8, and ∆10 troponin T, missing 4, 6, 8, and 10 
residues from the C-terminus, respectively. In our characterization of that truncation 
series at very low calcium concentrations, we showed that all fourteen of those C-
terminal residues are required for maintaining the blocked state. The number of 
residues removed from the C-terminus corresponded with progressive elimination of the 
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blocked state at very low calcium concentrations. Removal of all fourteen residues from 
the C-terminus appeared to be required to reach the maximal effect of reducing or 
eliminating the blocked state.  
The different methods used to calculate the distribution of actin in the blocked 
state were in agreeance that the blocked state was diminished as successive residues 
were removed from the C-terminus. There was some discrepancy between the different 
methods as to the magnitude of elimination of the blocked state by each truncation 
mutant. Figure 36 shows a plot of the relative blocked state population for each 
truncation mutant by the three different methods used. The acrylodan (circles) and 
excess myosin S1 (squares) method are in general agreement for every truncation. The 
excess pyrene actin method (triangles) is in agreeance with the other two methods for 
truncations ∆4, ∆6, and ∆8. For truncations ∆10 and ∆14, the excess pyrene method 
produces a greater relative blocked state population than the other two methods. 
The dashed line in Figure 36 is a representation of the blocked state population 
as a function of the number of residues deleted from the C-terminal of troponin T.  By 
the acrylodan method of measuring the blocked state distribution, the first four residues 
from the C-terminus (residues 285-288) were disproportionately important in 
maintaining the blocked state at very low calcium relative to the other C-terminus 
residues. Those four residues (29% of the C-terminus composition) appear responsible 
for 50% of the blocked state stabilizing function of the C-terminus. Notably, those 





Figure 36: The fraction of actin filaments in the B-state relative to wild-type values at low 
Ca2+ for different troponin T deletion mutants. Values were calculated from acrylodan 
tropomyosin fluorescence amplitudes (circles), the duration of the lag in binding of 
excess S1 to actin (squares), and from Eq. 1 (triangles). The latter were calculated 
using a different rate of binding in Ca2+ for each deletion mutant. The dashed line shows 
the expected behavior if each residue pair contributed equally to the effect measured. 
 
The assumptions used to calculate the blocked state population by the rate of S1 
binding to regulated actin are invalid 
Equations 3-5 are used to calculate the blocked state from the rate of binding of 
S1 to an excess of pyrene actin. Equation 4 is dependent on the assumptions that 1) 
the blocked state is absent at very low calcium concentrations and 2) myosin S1 binds 
at an approximately equal rate to the closed (C) and open (O) states. Differences in the 
value of kegta are expected to dictate the relative blocked state population for each 
troponin mutant while the value of kcalcium is expected to be equivalent for each troponin 
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mutant. The kcalcium value is measured from the rate of binding of myosin S1 to excess 
pyrene actin at saturating calcium.  
Contrary to the assumptions of equations 3-5, the rate of binding of myosin S1 to 
excess wild type pyrene-labeled actin filaments at saturating calcium, kcalcium, was not at 
a maximum value at saturating calcium. Rather the rate increased with each successive 
truncation of troponin T (Figure 20). Either the blocked state is not completely absent at 
saturating calcium and/or myosin S1 binds more rapidly to regulated actin in the open O 
state. The former possibility is unlikely as we see no acrylodan fluorescence increase 
signaling the appearance of the blocked state at saturating calcium (Figure 17). 
The relative amount of blocked state calculated from the binding of myosin S1 to 
excess pyrene actin (triangles) in Figure 36 was calculated using equations 3-5. The 
deviation of those triangles from other measurements is due to the invalid assumptions 
made in deriving those equations. Although this method may still be useful for 
demonstrating relative changes in the blocked state distribution, calculation of the 
relative blocked state or absolute blocked state using those equations is invalid. This 
brings into question all of the published data that use this assay to measure the blocked 
state distribution of different mutants. The Geeves30 model has been a popular 
substitute for the more complex Hill29,85 model. It will be necessary for those who have 
used the Geeves method to re-evaluate their data. 
By globally fitting the rate of myosin S1 binding to excess pyrene actin at very 
low and saturating calcium, we determined the rates of binding to the blocked, closed 
and open states to be 3, 6, and 13/sec, respectively. However, each of the traces could 
not be fit accurately using only two rate constants. Each of the traces at either very low 
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or saturating calcium concentrations could be fit using those three rate constants. These 
rate constants could be used to estimate the distribution of the three actin states.  
However, due to the relatively small differences (approximately 2-fold) between the 
rates of binding to each state, there is no unique fit to the three amplitudes.  For this 
reason, we cannot accurately calculate the absolute state distribution for each mutant 
using this method.  
Because of this evidence that the myosin S1 binding to excess pyrene actin 
method is invalid in calculating the absolute blocked state distribution, there is no longer 
a reliable method of calculating this absolute value. The two other methods used in this 
project, acrylodan tropomyosin fluorescence and excess myosin S1 binding to pyrene 
actin, only produce relative distributions in the blocked state. Each of these methods 
requires a standard value to convert the relative values into absolute values. If we knew 
the blocked state distribution of wild type troponin regulated actin, we could standardize 
our acrylodan traces to that value and calculate the state distributions. A future goal for 
research on contraction regulation will be to find independent methods of measuring the 
B state.  
A possible standard for the blocked state is troponin containing S45E TnI. This is 
the most inactivating troponin mutant yet observed and it is likely to approach 100% 
blocked state. This mutant produced an acrylodan tropomyosin fluorescence change 
corresponding to the closed to blocked transition that was 136% of that with wild type 
troponin regulated actin47. If we assume that mutant stabilized actin nearly 100% in the 
inactive state, this would allow us to calculate that wild type regulated actin is 
approximately 73% in the blocked state at very low calcium concentrations and this 
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value could be used as the standard for converting relative acrylodan fluorescence 
change values to absolute blocked state populations. To validate this method, we would 
need to identify a way to verify that the S45E TnI mutant is entirely or nearly entirely in 
the blocked state. This could possibly be done by using two mutations that each 
stabilize the blocked state. We showed earlier that the effects of multiple mutations is 
often additive69,78. 
 
Stepwise elimination of C-terminus stabilizes the open state in a graded manner 
The number of residues removed from the C-terminus also corresponded with 
progressive stabilization of the open state at saturating calcium concentrations. 
Removal of all fourteen residues produced about 70% occupancy of the O state at 
saturating calcium78. This is the maximum stabilization that can be obtained through 
alterations of the C-terminal region of troponin T. That is, all fourteen residues of the C-
terminus of troponin T contribute to destabilizing the O state. The last four residues of 
the C-terminus (residues 285-288) also appeared particularly important for maintaining 
the open state. Those four residues (29% of the total C-terminus composition) appear 
responsible for 40% of the open state destabilizing function of the C-terminus (Figure 
21).  
We had hypothesized that a specific residue or few residues could be attributed 
to the entire or majority of the C-terminus function of maintaining the blocked and open 
states. This however, was not the case. Though the terminal four residues (residues 
285-288, GRWK) contribute slightly more to this maintenance than the other ten 
residues (residues 275-284), all fourteen residues make an impact on both the blocked 
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and open state distributions. Truncation from the highly basic C-terminus corresponded 
with elimination of positively charged residues. Evidence from our truncation study 
suggested the positive charge of this region are critical for its function. Additionally, a 
hypertrophic cardiomyopathy associated mutation within this region, R278C troponin T, 
exhibits increased calcium sensitivity and force development86. These qualities are 
indicators of stabilization of the open state. Notably, this R278C troponin T mutation 
eliminates one of the basic charges within the C-terminus. 
 
Basic residues within the C-terminus of troponin T are responsible for stabilizing 
the blocked state and destabilizing the open state 
Based on evidence from the truncation study we developed a troponin T 
construct where the basic residues within the C-terminus were eliminated via 
substitution with alanine. For this construct, the seven lysine and arginine residues 
within the 16 C-terminal residues were substituted with alanine to eliminate all of the 
positive charge within the region. Additionally, we attached a cysteine residue to the C-
terminus, extending the length of the protein by one amino acid. We named this 
construct HAHA troponin T for high alanine, high activity. The high activity portion of the 
name was added only after we found the mutant did in fact enhance activity. 
Using the acrylodan method, we found the HAHA troponin T construct eliminated 
the blocked state at low calcium concentrations. Using the pyrene method, we similarly 
observed a decrease in the blocked state as evidenced by an increase in the rate of 
binding of myosin S1 to excess pyrene actin regulated by HAHA troponin T relative to 
that produced with wild type troponin T. Using the myosin ATPase assay, we found the 
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HAHA troponin T construct stabilized the open state at saturating calcium 
concentrations.  
By each of our measures of the actin state distribution, HAHA troponin T was 
indistinguishable from our functional measures of ∆14 troponin T regulated actin. 
Results from these assays with HAHA troponin T suggested that the basic charges 
within the C-terminus of troponin T are fundamental to its maintenance of the blocked 
state and the open state. Those basic residues stabilize the blocked state at very low 
calcium concentrations and destabilize the open state at saturating calcium 
concentrations.  
By eliminating basic residues within the C-terminus, we approximated the effect 
expected by addition of the negative charge associated with phosphorylation. In doing 
so, we showed a dramatic change in the state distribution that highlighted the 
significance of the charge balance of the C-terminus. Though the C-terminus residues 
275 and 284 can be phosphorylated via ROCKII or PKC, the physiological relevance of 
phosphorylation of those residues is unclear as they were not identified to be 
phosphorylated in mass spectrometric analysis of human tissue or mouse tissue68. 
Pseudophosphorylation by the mutation T285E troponin T has been shown to increase 
the calcium sensitivity corresponding with destabilization of the blocked state87. 
However, pseudophosphorylation by the mutation T287E did not exhibit any change in 
measures of tension or ATPase rate88. While the physiological relevance of 
phosphorylation of the C-terminus is questionable, phosphorylation may disrupt the 
normal mechanism of the C-terminus and shift actin to a more active state in a similar 
manner to that observed with elimination of the basic residues. 
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Basic residues within the C-terminus of troponin T increase the KM of actin 
The classical steric blocking model states that troponin places tropomyosin into a 
position on actin that blocks the myosin binding site.  The observation that regulatory 
proteins are able to increase the ATPase rate to a level higher than unregulated actin is 
not readily explained by that model. We are interested in the mechanism by which 
troponin and tropomyosin activate stimulation of the myosin ATPase 
Addition of calcium to regulated actin increases the Vmax of ATPase by 20-fold 
relative to low calcium conditions but only decreases the KM by 2-fold and leaves the 
affinity of S1-ATP for actin relatively unchanged89. However, calcium does not give fully 
activity and only stabilizes actin 30% in the open state78. Actin remains 70% in the 
closed state at saturating calcium. What changes occur going from the closed to the 
open state that are required for fully activity?  
Using N-ethylmaleimide S1 (NEM-S1), to stabilize actin in the fully active state, 
Williams et al. observed that actin in the fully active state produced a greater Vmax and a 
lower KM than regulated actin in the presence of calcium90. Those experiments present 
complications in that NEM-labeled S1 is used at high levels that act as a competitive 
inhibitor of S1-ATP binding. Thus, rather large corrections must be applied to the data.  
We took advantage of the troponin mutant A8V∆14 to stabilize the open state. Using 
troponin to stabilize the open state does not require corrections. 
 Our observed Vmax was 35 (±4) and 35 (±8) /second for unregulated actin and 
A8V∆14 regulated actin respectively. There was no appreciable change in the Vmax. 
The KM was 258 (±49) and 90 (±36) for unregulated actin and A8V∆14 regulated actin, 
respectively. The KM decreased significantly when actin was regulated by A8V∆14 
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troponin indicating that the transition from the closed to the open state population are 
the result of a decrease in the KM .This KM decrease agrees with that reported 
previously with NEM-S1 stabilized filaments90. 
In muscle cells, the actin concentration is well beyond the KM (up to 10 mM) and 
the rates should be near Vmax91. However, the Vmax may only be achieved when 
calcium is saturating. The sarcoplasmic reticulum regulates the calcium concentration in 
the cytosol of cardiac myocytes. With each heartbeat, the calcium concentration 
fluctuates between approximately 0.1 and 1 µM92. Even though the actin concentration 
in cardiac myocytes is near that required to reach the Vmax, the rate is also dependent 
on calcium reaching maximum saturation and possibly the presence of other activators 
not found in solution studies.  
These troponin mutations that apparently effect the KM should not appreciably 
affect the myosin ATPase rate when calcium is maximally saturating. The limits of 
sarcoplasmic reticulum control of calcium concentration are between approximately 0.1 
and 1 µM, however, that change is not instantaneous and the calcium concentration for 
some amount of time is intermediate to those limits. As well, those intermediate calcium 
concentrations may be more relevant in defects where elevation and/or removal of 
calcium from the cytosol are impaired. 
Both ∆14 and HAHA troponin T are convenient tools for stabilizing the active 
state of regulated actin. ∆14 troponin T has been exchanged into permeabilized skeletal 
and cardiac muscle fibers resulting in increased calcium sensitivity and decreased 
cooperativity of force production93. More recently, our colleague Dr. Jose Pinto has 
exchanged ∆14 troponin T into skinned trabeculae resulting in increased calcium 
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sensitivity and increased basal force (unpublished). Other colleagues, Drs. John 
Robinson and Christopher Solis-Ocampo showed actin filaments regulated by ∆14 
troponin T produced a 1.8x increase in speed of movement in the in vitro motility assay 
(unpublished).  
The fiber data were collected at conditions that more closely resemble the 
conditions found in a cell where the actin concentration is significantly higher. It has yet 
to be shown whether C-terminus mutation can affect the maximal force production in 
muscle fibers.  
 
The C-terminus of troponin T may interact with tropomyosin in a calcium 
dependent manner 
The previous studies using FRET to map distances within the thin filament take a 
global approach of mapping a variety of distances between actin, tropomyosin, and 
troponin subunits for use as constraints in molecular modelling34,75–77,94,95. Our study 
took a more focused approach to specifically measure distances from the C-terminus of 
troponin T. Our distances will ultimately be merged with those from other groups and 
used as constraints in molecular modeling simulations. We will not be able to fully 
analyze our results until those simulations are complete, but we can make conclusions 
based on the individual distance measurements in the context of what we already know 
about the interactions of actin, tropomyosin and troponin subunits.  
One primary goal of this project was to identify the specific residues of the C-
terminus of troponin T that modify the interactions of the C-terminus. We have now 
identified the basic residues of the C-terminus as being vital to function. The second 
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primary goal of this project was to identify the interactions of the C-terminus of troponin 
T and how mutation affects those and other known interactions.  
Our leading hypothesis is that residues near 275C in the C-terminus of troponin T 
have a high affinity for tropomyosin at low calcium and a low affinity at saturating 
calcium concentrations. Residues near 288K of troponin T have a low affinity for 
tropomyosin that is less dependent on calcium concentration. Based on this hypothesis, 
stabilization of the blocked state by the C-terminus occurs through a direct interaction 
that restrains tropomyosin primarily in that blocked position along actin. We propose the 
C-terminus of troponin T is in a more folded, less extended state that holds tropomyosin 
closer to troponin at low calcium concentrations. 
With an increase in calcium, we believe the C-terminus undergoes a decrease in 
folding and becomes more extended. This more extended conformation with an 
increase in calcium has been suggested previously77. Residues near 275C of troponin T 
dissociate from tropomyosin and release tropomyosin from the blocked state position 
along actin. Residues near 288K of troponin T remain bound to tropomyosin and limits 
actin to 30% open state population.  
 We created a simple scheme to model our interpretation of our data in the 
context of the known interactions within actin-tropomyosin-troponin (Figure 37). The C-
terminus of troponin T is represented in pink and emerges from the IT-Helix (pink with 
blue outline). The star indicates the approximate location of the very C-terminal residue 
288K of troponin T. The colored slices on actin represent the blocked (red), closed 
(yellow) and open (green) states that tropomyosin (grey) can occupy along actin.  
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At low calcium concentrations on the left-hand side of Figure 37, the C-terminus 
of troponin T is in a more folded conformation with extensive interaction with 
tropomyosin. The inhibitory region (Ip) of troponin I is bound to actin and the 
hydrophobic pocket on troponin C is not exposed. Tropomyosin is primarily in the 
blocked state position along actin with some population in the closed state. 
At saturating calcium concentrations of the right-hand side of Figure 37, the 
hydrophobic pocket of troponin C is opened and the regulatory or switch (Sw) region of 
troponin I is bound to that pocket. The inhibitory region of troponin I is dissociated from 
actin and interacts with troponin C. Binding of the switch region and inhibitory region of 
troponin I to troponin C causes a conformational change in the IT-helix that is 
immediately adjacent to the inhibitory region of troponin I. The conformational change of 
the IT-Helix induces a conformational change in the C-terminus of troponin T where 
residues near 275 of troponin T are positioned closer to troponin C. Calcium induced 
changes in troponin C expose interaction sites with residues near 275 of troponin T to 





Figure 37: Scheme for our proposed model of the Interactions of the C-terminus of 
troponin T at low (left) and saturating calcium (right). The large circle represents a single 
actin monomer viewed looking down a strand of polymeric actin. The colored slices in 
the circle represent the blocked (red), closed (yellow), and open (green) positions that 
tropomyosin (grey) can occupy along actin. The C-terminus of troponin T is shown in 
pink and the star indicates the approximate location of the last terminal residue 288K. 
The IT-Helix is represented by the pink shape with blue outline. Ip is the inhibitory 
peptide (or inhibitory region) of troponin I. Sw is the switch region (or regulatory region) 
of troponin I. Troponin C (TnC) is shown in light green. The dotted section of troponin C 
without calcium bound represents the hydrophobic patch that opens in response to 
calcium binding. For simplicity, many protein regions are not shown. One omission is 
the mobile region of troponin I that interacts with tropomyosin at low calcium but 
dissociates at saturating calcium. 
 
Changes in the C-terminus conformation resulting from repositioning of the IT-
Helix and binding to troponin C stabilize the C-terminus in a more extended 
conformation. Residues near 288 of troponin T are less dependent on calcium and 
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remain associated with tropomyosin. The extended conformation allows tropomyosin to 
move out of the blocked state in response to calcium and partially into the open state. 
The interaction between residues near 288 of troponin T and tropomyosin limits open 
state occupancy at saturating calcium.  
When the basic residues of the C-terminus of troponin T are eliminated (as in 
∆14 or HAHA troponin T), the interaction with tropomyosin is eliminated. At low calcium 
concentrations, the basic residues of the C-terminus are not available to restrain 
tropomyosin in the blocked position. Tropomyosin is stabilized almost entirely in the 
closed position at low calcium concentrations because calcium is still required to relieve 
some of the other restraints imposed by troponin on the tropomyosin position. When the 
basic residues of the C-terminus are eliminated at saturating calcium, the open state is 
stabilized to a greater extent than with wild type troponin because the interaction 
between residues near 288 of troponin T with tropomyosin are eliminated.  
Evidence in support of this model (Figure 37) come from our and from the work 
of others. For the FRET pair between IAEDANS 275C troponin T and DABMI C190 of 
tropomyosin, we measured a transfer efficiency of 0.86 and 0.55 at very low and 
saturating calcium respectively. From this efficiency we calculated a distance of 30 and 
39 Å at very low and saturating calcium respectively. The very high transfer efficiency at 
a very low calcium concentration suggested the possibility that those two locations may 
interact or are at least close to one another. The large increase in distance for the FRET 
pair between IAEDANS 275C troponin T and DABMI C190 of tropomyosin suggested 
that these two regions moved away from each other with an increase in calcium.  
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IAEDANS 289C troponin T was measured to be further away from C190 
tropomyosin at low calcium compared to 275C troponin T. The magnitude of the change 
in distance between 289C troponin T and C190 tropomyosin however was not as large 
as that for 275C troponin T. This indicated that the distance between 289C troponin T 
and C190 tropomyosin was not as significantly affected by calcium. 
Because the inhibitory region of troponin I is immediately adjacent to the IT-Helix, 
binding of the inhibitory region to troponin C may result in a reorientation of the IT-Helix 
that repositions or changes the conformation of the C-terminus of troponin T. Molecular 
dynamics simulations provided evidence that a hydrogen bond forms between troponin 
T residue R278 and troponin C residue D151 in the calcium saturated state77. However, 
this movement of troponin T to troponin C must be verified experimentally. Alternatively, 
calcium induced changes in troponin C may expose residue D151 for hydrogen bonding 
to R278 of troponin T. This interaction may in turn induce binding of the regulatory 
region and inhibitory region of troponin I to troponin C.  
We observed a relatively high efficiency of transfer between IAEDANS 275C 
troponin T and DABMI T143C troponin I at low and saturating calcium. This supports 
the idea that those region’s movement is concerted and that residue 275C of troponin T 
is repositioned onto troponin C along with repositioning of the inhibitory region of 
troponin I. A relationship between the inhibitory region of troponin I and the C-terminus 
of troponin T is also supported by evidence that a troponin T C-terminus mutation 




A chymotryptic fragment corresponding to cardiac troponin T residues 268-288 
was shown to interact with whole troponin I using affinity chromatography, gel filtration, 
and circular dichroism96. This interaction was weaker than with the troponin T fragment 
(residues 205-259) containing the IT-Helix domain but this indicated that troponin T and 
troponin I may interact weakly beyond the C-terminus of the IT-Helix. Though this 
interaction is weak, it may assist in keeping the C-terminus of the inhibitory region close 
for a concerted calcium response. 
Our model requires that the known calcium responses of troponin (hydrophobic 
pocket of troponin C opening, dissociation of troponin I inhibitory region from actin, 
binding of troponin I regulatory and inhibitory regions to troponin C) are functional 
regardless of the presence of basic residues within the C-terminus. This is because 
troponin must inhibit entry into the open state even when the basic residues of the C-
terminus are eliminated. We observed that the distance between troponin I T143C and 
actin C374 was dependent on the presence of ∆14 troponin T at low and saturating 
calcium concentrations. The distance for wild type troponin at saturating calcium (58 Å) 
with ∆14 troponin T at low calcium (50 Å). Although ∆14 troponin T causes some 
apparent destabilization of the interaction between troponin I and actin, ∆14 troponin T 
does not eliminate the binding of troponin I inhibitory region to actin. 
 
Time courses of FRET efficiency changes suggests concerted calcium response 
The change from the initial efficiency to the final efficiency for the FRET pair 
between IAEDANS 275C troponin T and DABMI C190 of tropomyosin occurred with a 
rate of 7.0/second. That value corresponds to the rate of the movement of IAEDANS 
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275C troponin T and DABMI C190 of tropomyosin relative to one another as actin 
redistributes from the open state into the closed and blocked states. One of the steps in 
determining the mechanism of the C-terminus function, is to identify the order of events 
involved in activation and which appear to be coupled and occur simultaneously. Using 
the acrylodan probe on tropomyosin, we previously measured that for wild type troponin 
regulated actin, the closed to blocked state transition occurs at a rate of 6.8/second. 
The rate of the closed to blocked transition occurs at a nearly equivalent rate to that of 
the movement of 275C troponin T relative to C190 of tropomyosin. This similarity in rate 
suggests that the movement of 275C troponin T relative to C190 of tropomyosin is 
simultaneous with the transition of actin from the open state into a mixture of the closed 
and blocked states. 
The time course of the efficiency change as actin redistributes from the open 
state into the closed and blocked states was also measured for the FRET pair 
IAEDANS 289C troponin T with DABMI C190 of tropomyosin. As with the steady state 
efficiency measurements, this FRET pair is closer when actin is in a more active state 
although farther apart than the IAEDANS 275C troponin T – DABMI C190 tropomyosin 
pair. The rate of the transition of these two regions relative to each other is 7.0/second 
at 10° C indicating this transition also occurs in concert with redistribution from the pen 
state into the closed and blocked states.  
 This transition was greatly altered when the basic residues in the C-terminal 
region of troponin T was replaced with alanine residues. Upon myosin S1 dissociation 
from actin, the IAEDANS HAHA 289C troponin T-DABMI C190 tropomyosin FRET pair 
does not exhibit the efficiency change that was observed for the IAEDANS 289C 
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troponin T-DABMI C190 tropomyosin FRET pair. The efficiency stays relatively constant 
throughout the redistribution of actin from the O state to the C state. Elimination of this 
efficiency change over the time course of the reaction is the result of no change in 
distance between 289C troponin T and C190 tropomyosin due to elimination of the 
basic residues in the C-terminus of troponin T. This distance change may only occur 
between the closed and blocked states. As the blocked state is eliminated for HAHA 
troponin T regulated actin, that distance change was not observed.  
 
Development of a FRET sensor to measure troponin I inhibitory region binding to 
actin 
The FRET pair between IAEDANS T143C Troponin I and DABMI C374 of actin 
was chosen in part to develop a FRET sensor to monitor the binding of the inhibitory 
region of troponin I to actin. Residue T143C is in the inhibitory region of troponin I that is 
known to bind actin at low calcium concentrations and dissociate as the calcium 
concentration increases. We calculated a distance of 48 and 58 Å at very low and 
saturating calcium, respectively. This increase in distance as calcium increases 
corresponds with dissociation of the inhibitory region of troponin I from actin.  
This FRET sensor may be useful in measuring how troponin mutation affects the 
mechanism of the inhibitory region of troponin I binding actin. The distance between 
these two regions may also be useful in calculating the actin state distribution if the 
distance is known for actin stabilized in each state. One of the primary goals of this work 
is identifying the mechanism of disruption to the actin state distribution by mutation in 
the C-terminus of troponin T. We tested this sensor in the presence of the activating 
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∆14 troponin T mutant. Because that mutation eliminates the blocked state, we 
hypothesized the interaction of the inhibitory region of troponin I with actin would be 
disrupted.  
The FRET pair between IAEDANS T143C Troponin I and DABMI C374 of actin in 
the presence of ∆14 troponin T resulted in an increase in distance, compared with wild 
type, from 48 to 50 Å at very low calcium and from 58 to 68 Å at  saturating calcium. At 
low and saturating calcium concentrations, the distance of the FRET sensor is greater 
when ∆14 troponin T is present, indicating that mutation in the C-terminus of troponin T 
is coupled to interruption of the binding of the inhibitory region of troponin I to actin. 
Though the distance is increased resulting from ∆14 troponin T, we do not believe ∆14 
troponin T has eliminated this regulatory mechanism. 
We measured this FRET sensor IAEDANS T143C Troponin I and DABMI C374 
of actin with and without ∆14 troponin T present at several calcium concentrations to 
determine whether this FRET sensor is responsive over physiologically relevant calcium 
concentrations. Additionally, we sought to determine whether the presence of ∆14 
troponin T affected the calcium sensitivity of the interaction of the inhibitory region of 
troponin I with actin. Figure 34 shows a plot of this experiment where the efficiency is 
plotted versus the calcium concentration.  
Those data were fit with a Hill equation to determine the pCa50 and Hill 
coefficient (cooperativity) of the calcium titration. The pCa50 was determined to be 4.4 
and 4.2 in the absence and presence of ∆14 troponin T respectively. This indicated that 
this FRET sensor is responsive near the physiological range of calcium concentrations 
associated with deactivation and activation. The Hill coefficient was reduced from 16.1 
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to 15.7 with ∆14 troponin T which indicated the transition was slightly less cooperative. 
Rat cardiac skinned trabeculae produced a hill coefficient of 4.3 and 4.2 for wild type 
and ∆14 troponin T respectively97 which agreed with the trend we observed.  
The pCa50 values indicate that the mutation resulted in a decrease in the calcium 
sensitivity of the movement of T143C troponin I relative to actin C374. Although the 
difference in sensitivity is small, it is in opposition to the increase in calcium sensitivity 
previously with ∆14 troponin T. Rat cardiac skinned trabeculae produced a pCa50 of 
5.25 and 5.45 for wild type and ∆14 troponin T, respectively97. As previous measures of 
pCa50 were completed in skinned fibers, it is possible that this discrepancy is a result of 
proteins and geometric constraints that are absent in our solution studies. 
This FRET pair between T143C of troponin I and C374 of actin appears useful in 
measuring the binding of the inhibitory region of troponin I to actin. One disadvantage of 
this FRET pair is that the efficiency of transfer is low even at low calcium 
concentrations. Because we know that the inhibitory region of troponin I binds to actin at 
low calcium concentrations, we would expect a greater transfer efficiency. However, the 
DABMI probe on actin in this FRET pair is likely in a location distant from the inhibitory 
region binding site.  
An ideal FRET pair would produce a transfer efficiency closer to 0.5 as this value 
is at the R0 for a particular FRET pair which can more accurately predict the distance. At 
very low or very high efficiency values, small changes in efficiency produce large 
changes in distance. A different acceptor location on actin might produce a greater 
transfer efficiency with the IAEDANS probe on T143C of troponin. This is more 
complicated than using the native easily targeted cysteine 374 of actin. A FRET sensor 
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between the C-terminus of troponin T and actin residue Q41 has been shown to exhibit 
a high transfer efficiency34. That location of actin may be a more ideal acceptor location 
for measuring the interaction between the inhibitory region of troponin I and actin.  
 
Use of FRET to validate structure-function relationships and potential for use in 
calculating state distributions  
∆14 troponin T produces a different distribution of states than wild type troponin 
T. At low calcium concentrations, actin filaments containing wild type troponin T are 
primarily in the blocked state, but they are in the closed state with ∆14 or HAHA 
troponin T. At saturating calcium, wild type filaments are in a mixture of 70% closed and 
30% open states whereas ∆14 or HAHA troponin T containing filaments are 30% closed 
and 70% open.  
If the motion of the C-terminus of troponin T occurs along a straight trajectory, 
one can estimate the distance between the inhibitory region troponin I residue T143C 
relative to actin in each actin state. Wild type troponin regulated actin at low calcium 
concentrations is primarily in the blocked state and produces a T143C Troponin I - C374 
actin distance of 25 Å. ∆14 troponin T regulated actin at low calcium concentrations 
should be almost entirely in the closed state and produces a T143C Troponin I - C374 
actin distance of 50 Å. Wild type troponin at saturating calcium produces a T143C 
Troponin I - C374 actin distance of 58 Å. We can calculate the distance between T143C 
troponin I and C374 of actin in the open state using these distance values for the 
blocked and closed state.  
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Using the equation 58 Å = 0.7*50 Å + 0.3*M Å we can calculate that the open 
state distance is 77 Å. Similarly, 14 troponin T regulated actin produces a T143C 
Troponin I - C374 actin distance of 68 Å. Using the equation 68 Å = 0.3*50 Å + 0.7*M Å 
we can calculate that the open state distance is 76 Å.  
We will use molecular dynamics modeling with Dr. Yumin Li (East Carolina 
University Chemistry Department) to estimate the distances using different probes and 
generate a more realistic model. It should be possible, as shown in the simple example 
here, to calculate the distribution of states from FRET analyses. This should solve the 
problem of calibrating the acrylodan-tropomyosin and pyrene-actin fluorescence 
changes discussed earlier.  
 
The C-terminus of troponin T does not bind near actin C374 but may bind 
elsewhere on actin 
The FRET pair between IAEDANS 275C troponin T and DABMI C374 of actin 
produced a distance of 48 and 55 Å at very low and saturating calcium, respectively. 
The FRET pair between IAEDANS 289C troponin T and DABMI C374 of actin produced 
a distance of 56 and 58 Å at very low and saturating calcium, respectively. Neither 275C 
or 289C of troponin T appear to interact near residue 374C of actin at low or saturating 
calcium concentrations.  
The FRET pair between IAEDANS HAHA 289C troponin T and DABMI C374 of 
actin was investigated to identify how elimination of the basic residues within the C-
terminus of troponin T affected the possible interaction between the C-terminus and the 
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highly negatively charged surface of actin. We calculated a distance of 65 and 63 Å at 
very low and saturating calcium, respectively.  
As the calcium concentration increases from very low to saturating, we know for 
wild type troponin regulated actin, that the blocked state is eliminated, and actin 
redistributes primarily into the closed state. During this calcium induced redistribution, 
residue 275C and 289C of troponin T move further from actin C374. For ∆14 or HAHA 
troponin T regulated actin, the blocked state is eliminated at low calcium concentrations. 
The distance between IAEDANS HAHA 289C troponin T and DABMI C374 of actin at 
low calcium concentrations is greater than the wild type 289C distance at saturating 
calcium. Although the C-terminus does not appear to interact near actin C374, the 
distance is affected by elimination of the blocked state. 
Because the distance for the FRET pair actin C374 - troponin T 275C is lower 
than that of the FRET pair actin C374 – troponin T 289C, this suggests that the C-
terminus is oriented in a manner where residue 289C is farther from C374 actin and 
residue 275C extends toward C374 of actin. Molecular modelling simulations will be 
performed using these distances as constraints to better predict the orientation of the C-
terminus relative to actin.  
Though our FRET data does not suggest binding of the C-terminus of troponin T 
near C374 of actin, this does not mean the C-terminus could not bind elsewhere on 
actin. Of note is that the distance measured between the inhibitory region of troponin I 
and C374 of actin also did not suggest binding at that site, although we know the 
inhibitory region binds actin at low calcium concentrations. This hypothesis that the C-
terminus of troponin T interacts with actin is based on the observation of spatial and 
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sequence homology of the C-terminus of troponin T with the inhibitory region of troponin 
I that is known to bind actin69. 
 We additionally presented evidence that a peptide consisting of the C-terminal 
sixteen residues of troponin T decreased the ATPase rate of unregulated actin in a 
concentration dependent manner. We showed this was the result of the peptide causing 
actin to precipitate. This is likely the result of the highly basic C-terminal residues of 
troponin T binding to the negatively charged surface of actin and making it insoluble. 
This does not prove that actin is the binding site for the C-terminus of troponin T as 
many positively charged peptides likely would cause the same outcome. However, this 
does show that the C-terminus has the potential to bind actin. Whether that interaction 
is physiologically relevant is still to be identified.  
 
Summary of Conclusions from Each Individual FRET pair 
For each FRET pair, we obtained a distance that will be used as constraints in 
molecular modelling simulations to map the crystal structure of troponin and 
tropomyosin onto actin. In Table 5, the justifications for each of our FRET pair choices 
was summarized. Table 10 and Table 11 below summarize the conclusions regarding 




Table 10: Conclusions regarding justifications for FRET experiments where DABMI 








275C of TnT does not appear close enough to interact specifically 
near C374 of actin though it could interact elsewhere on actin. 
275C is closer to C374 of actin than 289C at low calcium 
concentrations. The distance from this actin location increases 





289C of TnT does not appear close enough to interact specifically 
near C374 of actin though it could interact elsewhere on actin. 
289C is further from C374 of actin than 275C at low calcium 
concentrations The distance from this actin location increases 






Elimination of the positively charged residues within the C-
terminus of TnT shifts the C-terminus further from this location on 
actin. The low calcium distance of HAHA TnT resembles that of 





The efficiency of transfer is lower at saturating calcium. This 
agrees with the mechanism of the inhibitory region of TnI 






The inhibitory region is further from actin at low calcium 
concentrations when in the presence of the activating Δ14 TnT 






Table 11: Conclusions regarding justifications for FRET experiments where DABMI 
C374 actin is the acceptor 
Donor Acceptor Result 
TnT 275C C190 of Tpm These two locations are close and direct interaction 
may be near these residues. Distance is greater at 
saturating calcium. 275C is closer than 289C to Tpm 
C190 at saturating calcium 
TnT 289C C190 of Tpm These two locations are close and direct interaction 
may be near these residues. Distance is greater at 
saturating calcium.  
HAHA TnT 
289C 
C190 of Tpm Distance is greater in the presence of the activating 
HAHA TnT mutant. Removal of basic residues disrupts 
this interaction. 
TnI T143C C190 of Tpm The distance between inhibitory peptide binding site on 
actin and Tpm at very low calcium concentrations is 
approximately 34 Å. The distance between the TnI 
binding site on TnC and Tpm at saturating calcium 
concentration is approximately 40 Å 
TnI T143C 
Δ14 TnT 
C190 of Tpm The ∆14 TnT mutant causes the distance between 
actin inhibitory region and Tpm C190 to increase or the 
TnI inhibitory region binding to actin is disrupted at low 
calcium. Also causes the distance between the TnI 
binding site on TnC and Tpm C190 to increase or the 
TnI inhibitory region binding to TnC is disrupted at 
saturating calcium.  
TnT 275C 143C of TnI 275C of TnT and inhibitory region of TnI have relatively 
high transfer efficiency. The two regions may have a 
shared function. The distance between these two 
locations is independent of calcium concentration. 
TnT 289C 143C of TnI 289C of TnT and inhibitory region of TnI have relatively 
high transfer efficiency but lower than 275C. The two 
regions may have a shared function. The distance 







An alternative or addition to this model is that some residues of the C-terminus of 
troponin T may interact with actin at low or saturating calcium. Though our FRET data 
do not suggest an interaction, the C-terminus of troponin T could interact elsewhere on 
actin. The C-terminus might normally position tropomyosin via this actin interaction and 
set the calcium induced limits of the actin state distribution. Upon elimination of the 
basic residues of the C-terminus, that interaction would be eliminated. Actin can also be 
modified with fluorescent probes at C10 and Q4134. Those locations might prove to be 
more useful in identifying an interaction with the C-terminus of troponin T. Additionally, 
those measurements would be useful as constraints in our molecular modelling 
simulations. 
The distance between the inhibitory region of troponin and actin is increased by 
the presence of ∆14 troponin T. The inhibitory region of troponin I is believed to bind 
troponin C at saturating calcium concentrations. It is possible mutation in the C-terminus 
of troponin T also disrupts binding of the inhibitory region of troponin I to troponin C. 
Alternatively, mutation to the C-terminus of troponin T might stabilize that interaction. 
This could be more directly measured with a FRET sensor between inhibitory region of 
troponin I and troponin C. Measuring that distance might prove to be a more ideal FRET 
sensor for measuring the mechanism of the inhibitory region of troponin I. Those 
measurements would also be useful as constraints in our molecular modelling 
simulations. 
The A8V∆14 troponin mutant has been shown to give almost total stabilization of 
actin in the open state at saturating calcium. We used the ∆14 or HAHA troponin T 
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mutant in our FRET assays to monitor structural consequence of stabilization of the 
open state. Though those mutants stabilize the open state, they are not as stabilizing as 
the A8V∆14 construct. Incorporation of A8V∆14 would allow a more direct observation 
of the structure of the open state. 
Sarcomeric modulators such as the peptide consisting of the last sixteen 
residues of the C-terminus of troponin T may be able to affect the interactions required 
for the C-terminus of troponin T to maintain the actin state distribution. Since the 
importance of the high positive charge in this highly conserved C-terminus is now 
evident, it is likely this region interacts with a negatively charged region. A sarcomeric 
modulator could disrupt that negatively charged region to destabilize that interaction of 
the C-terminus of troponin T. If an interaction associated with the blocked state was 
disrupted, this would destabilize the blocked state and shift the actin state distribution to 
a more active state. This could be a useful mechanism in restoring contractile activity in 
heart disease or other diseases where the actin state distribution might be affected.  
We currently have limited sarcomeric modulators available for affecting the actin 
state distribution. Bepridil is a calcium sensitizer that is known to bind the troponin C 
hydrophobic pocket98. Bepridil has been shown to increase ATPase rates and isometric 
force in muscles fibers99 presumably by stabilizing the hydrophobic pocket of troponin 
C. While bepridil increased the activity at low calcium concentrations, it produced a 
slight inhibitory effect at saturating calcium suggesting stabilization of the closed 
state100.  
Stabilization of the closed state may be useful in some cases, but the distribution 
of actin among all three states at both low and saturating calcium must be considered 
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for restoring contractile activity. A shorter or longer peptide than the ∆16 troponin T 
peptide we tested may prove more useful for modulating activity. Molecular modelling 
along with identifying the binding site of the C-terminus of troponin T may allow 
computation of small molecules that effect the troponin T C-terminus interaction. A small 
molecule that targets the interactions of the C-terminus of troponin T may prove to be 
useful in stabilizing the closed state at low calcium concentrations and the open state at 





  We have established that the basic residues within the C-terminus of 
troponin T are essential in that region’s maintenance of the actin state distribution. At 
low calcium concentrations, those basic residues stabilize tropomyosin in the blocked 
state along actin. At saturating calcium concentrations, those residues stabilize 
tropomyosin primarily in the closed position along actin. Elimination of the basic 
residues within the C-terminus of troponin T results in stabilization of tropomyosin in the 
closed and open states at low and saturating calcium respectively.  
 As suggested in part by the 86% transfer efficiency observed between IAEDANS 
275C troponin T and DABMI C190 tropomyosin, the most likely target for the C-terminus 
of troponin T at low calcium concentrations is tropomyosin. The time course of the 
efficiency change for FRET pairs between the C-terminus and tropomyosin C190 are 
similar to the time course of the transition from the closed to open state. The movement 
of the C-terminus of troponin T relative to tropomyosin C190 is simultaneous with 
repositioning of tropomyosin. 
Our model shown in Figure 37 is a working hypothesis based on the evidence 
obtained in our lab and the known interactions of actin-tropomyosin-troponin. That 
model is a two-dimensional visualization of a very complicated three-dimensional 
system. We will incorporate our efficiency and distance measurements into molecular 
modelling simulations to develop a better visualization of our data. Still, there are many 
remaining pieces to this puzzle necessary to validate this model.
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Appendix A: IACUC Approval letter 
 
 
Appendix B: Protein Preparation and Protocols  
 
Skeletal Actin Preparation 
Adapted from Ebashi, S.; Kodama, A. J Biochem 1965, 58 (1), 107–108. 
Day 1 
1.  Make 2 liters G-actin buffer 
a. 0.5 mM ATP, 2 mM Tris-pH 7.8, 0.1 mM CaCl2, B-mercaptoethanol 
2. Add 270 ml of actin solution /9 g powder. Gently stir every 10 minutes for 30 
minutes. Stir gently so as not to extract actinin or tropomyosin. 
3. Centrifuge 60 minutes near top speed of Sorvall SS-34 rotor (18,000 rpm) 
4. Tare empty beaker. Filter supernatant into beaker through glass wool or Whatman 
# 541 paper. Approximate volume by mass. 
5. Add solid potassium chloride to 3.3 M 
a. assume that potassium chloride increases the volume by 10 % 
6. Stir at room temp until the temperature reaches 15 C.  
7. Place on ice without stirring until temp reaches 5 C.  
8. Centrifuge in Sorvall SS-34 rotor at 18,000 rpm for 40 minutes. 
9. Dialyze supernanant against 32 volumes of 2 mM Tris, 1mM MgCl2 pH 7.6. The 
final concentration of KCl is now 0.1 M. Actin is now in “F” form. 
 
Day 2 
10. Add 4 M KCl to the actin to give a final concentration of 0.8 M.  
a. Volume of KCl to add is 0.219 x volume of actin.  
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11. Stir for 1 hour at 4C.  
12. Centrifuge for 1.5 hour at 45,000 rpm in a Ti 50.2 rotor.  
13. Remove pellets into homogenizer with less than 25 ml of G-buffer and 
homogenize  
14. Tare a beaker (150 ml) and add actin to estimate volume by its mass. 
15.  Add sequentially with stirring: 1.5 ml 100 mM MgCl2, 0.75 ml 4 M KCl, G-buffer to 
bring total volume to 77.25 ml 
16. Place on ice over night or proceed to Day 3\ 
 
Day 3 
17.  Add 18 ml of 4 M KCl and 4.75 ml G-buffer 
18. Stir for 1.5 hours at 4C. 
19. Centrifuge 1.5 hours at 45,000 rpm in Ti 50.2 rotor.  
20. Remove pellets into homogenizer with less than 25 ml of G-buffer and 
homogenize. 
21.  Dialyze against G-buffer with at least three changes of buffer. Change buffer 
every 12 hours.  
 
Day 5 
22. Homogenize G-actin.  
23. Centrifuge 1.5 hours at 30,000 RPM in a Ti 50.2 rotor. 
24. Weigh the actin to estimate the volume.  
25. While stirring vigorously add sequentially: 1 M MOPS pH 7 buffer to get 10 mM, 
25 mM MgCl2 to get  1 mM 
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26. Dialyze in F-actin solution at least 24 hours 
a. 4 mM MOPS, pH 7, 2 mM  MgCl2 , 0.5 mM ATP 
27. Add sodium azide to the actin to a final of 0.01%.  
28. Store actin at 4C 
 
Removal of residual ATP before use 
29. Centrifuge at 45,000 RPM for two hours in a Ti 50.2 rotor 
30. Pour off supernatant and set aside (check O.D. to ensure low actin concentration) 
31. Remove pellet into homogenizer with less than 10 ml F-actin solution and 
homogenize 
32. Measure Absorbance spectrum from 260 nm to 340 nm 
33. ATP-free actin should exhibit the following 
a. A280/A290=1.8 
b. A280/A260=1.5 
34. Concentration in mg/ml = (A280-A320)/1.15  
 
Storage 
Store in G-actin form at 5mg/l by adding surcrose to 10mg/ml or by freezing in liquid 




Adapted from: Leonard A. Stein, Richard P. Schwarz Jr., P. Boon Chock, and Evan 
Eisenberg. Biochemistry 1979 18 (18), 3895-3909 DOI: 10.1021/bi00585a009 
 
Day 1 
1. Kill 5-6 lb rabbit by bleeding. 
2. Dissect back and leg muscles quickly and place on ice 
3. Grind and weigh. (Should have about 300 grams) 
4. Extract 12 minutes with 3 volumes of ice cold extracting solution. Stir in cold. 
a. 0.5 M KCl, 0.1 M K2HPO4, 10 mM PMSF, pH 6.5 
5. Centrifuge at 7,000 RPM, 4 degrees Celsius for 15 minutes in GSA rotor.  
6. Filter supernatant through four layers of cheesecloth and collect. Estimate 
volume. 
a. Pellet may be saved for acetone powder prep 
7. Carefully adjust to pH 6.6 
8. Dilute with 10 volumes ice cold water over the course of 2-3 minutes 
9. Check that pH is still below 6.8 and correct as needed 
10. Centrifuge at top speed in IEC rotor. Discard supernatant. 
11. Weight pellets to estimate volume 
12. Add 2 M KCl to 0.5 M to make solution 
a. Liters 2M KCl = 0.303 x volume pellet 
13. Pool pellets into one bottle. Rinse residual protein from bottles with 0.5 M KCl. 
Keep total volume under 550 mL 
14. Adjust pH to 6.75 using 0.1 M NaHCO3 
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15. Measure volume 
Day 2 
16. Dilute to 0.28 M KCl with ice cold water with stirring 
a. Volume Cold Water = volume solution x 0.786 
17. Centrifuge at top speed in Sorvall GSA rotor 
18. Discard precipitate 
19. Measure supernatant volume 
20. Dilute to 0.4 M KCl with ice cold water and stirring 
a. Volume Cold Water = volume solution x 6 
21. Allow to stand one hour in the cold 
22. Centrifuge at top speed in IEC rotor for 20 minutes 
23. Discard supernatant 
24. Combine and weigh pellets to estimate volume 
25. Bring to 0.5 M KCl with ice cold 2 M KCl and stir to dissolve 
a. volume 2 M KCl = volume pellets x 0.3 
26. Dialyze versus 1 liter of 0.5 M NaCl, 0.1 mM DTT 
Storage 




Myosin S1 Preparation 
Adapted from: Leonard A. Stein, Richard P. Schwarz Jr., P. Boon Chock, and Evan 
Eisenberg. Biochemistry 1979 18 (18), 3895-3909 DOI: 10.1021/bi00585a009 
 
Day 1 
1. Dialyze myosin 50% glycerol stock extensively against 30 mM NaCl, 2 mM 
MOPS pH 7, 1 mM DTT. 
Day 2 
2. Centrifuge in Sorvall SS-34 rotor at 18,000 RPM for 1 hour 
3. Discard supernatant 
4. Estimate pellet volume and dissolve myosin by adding solid KCl to 1 M 
5. Suspend the pellets in 0.5 M NaCl, 10 mM MOPS pH 7, 1 mM DTT and dialyze 
against same buffer 
Day 3 
6. Measure the concentration and dilute to 15 mg/ml if needed 
7. Dialyze overnight against 0.12 M NaCl, 10 mM NaPi pH 7.2, 1 mM EDTA, 1 mM 
DTT, 0.1 mM NaN3 
Day 4 
8. Measure myosin volume 
9. Prepare 100 mM PMSF by dissolving 34 mg in 1 mL isopropyl alcohol. Dissolve 
by warming and sonicating. 
10. Prepare chymotrypsin by dissolving 5 mg in 1 mL water. Store on ice. 
11. Warm myosin to 22-25 degrees Celsius 
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12. Add chymotrypsin solution using a 1/100 dilution with rapid stirring. Final 
concentration is 0.05 mg/ml 
13. Maintain myosin temperature between 22 and 25 degrees Celsius and stir ten 
minutes 
14. Add 100 mM PMSF using a 1/200 dilution with rapid stirring. Final concentration 
0.5 mM. 
15. Allow to set in ice 10 minutes 
16. Dialyze over night against 40 mM NaCl, 5 mM NaPi, 1 mM DTT, pH 6.5 at 4 
degrees Celsius 
Day 5 
17. Centrifuge at 40,000 RPM for one hour in a Ti 50.2 rotor 
18. Collect supernatant 
19. Precipitate the S1 by adding 100% ammonium sulfate to 60% saturation 
20. Centrifuge at 18,000 RPM in sorvall SS-34 rotor for 30 minutes 
21. Pour of supernatant 
a. Pellets can covered with 60% ammonium sulfate at this step and kept on 
ice for two months 
22. Dissolve pellet in 2 mM MOPS pH 7, 50 mM KCl, 1 mM DTT and dialyze versus 
same buffer 
Day 6 




Preparation of Ether powder from bovine cardiac muscle for the production of 
troponin and tropomyosin 
Adapted from: Potter (1982; volume 85 of methods in Enzymology) 
 
At 4 degrees C 
1) Mince trimmed beef cardiac muscle 
2) Add 5 volumes of wash solution and homogenize.  
a. 1% triton, 50 mM KCl, 5 mM Tris pH 8 
3) Homogenize 1 minute at high speed (5-7) 
4) Centrifuge at 10960 g for 15 min. Discard supernatant. 
5) Pellets are suspended in equal volume of wash solution in centrifuge bottle and 
rehomogenized 
6) Centrifuge at 10960xg for 15 min 
7) Repeat steps 5-7, 8-10 times (cardiac residue turns almost white) 
At room temp 
8) Pellets transferred to a 4 Liter plastic beaker 
9) Three volumes cold 95% ethanol added 
10) Break up pellets with gloved hand 
11) Tissue is collected over Buchner funnel on 4 liter filter flask. 26cm diameter, 
Whatman No. 1 filter paper. Discard filtrate 
12) Repeat steps 1-5, 3 more times 
13) Repeat steps 1-6 using diethyl ether in place of ethanol 
14) Leave to dry overnight on filter paper 
15) Weigh and store at 4 degrees C  
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Preparation of Bovine Cardiac Troponin from Ether Powder 
Adapted from: Potter (1982; volume 85 of methods in Enzymology) 
 
1. Bovine cardiac ether powder is extracted in a 20 vol/gram powder of 1M KCl, 20 
mM MOPS, pH7.0, 1 mM DTT, 0.01% NaN3, 25 mg/L Benzamidine, 10 mg/L  
Leupeptin, 5 mg/L Pepstatin A , 10 mg/L TLCK, 3 mg/l TPCK, 15 mM BME 
2. Stir overnight at 4C. 
3. Centrifuge 1 hour at 45,000 rpm in a Ti50.2 rotor. 
4. Carefully remove supernatant and adjust to pH 8.0 with 1N KOH. 
5. Measure volume  
6. Add 167g of  ammonium sulfate per liter of supernatant with constant stirring at 4 
degrees Celsius  
7. Allow to stir one hour 
8. Centrifuge in Sorvall SS-34 rotor for 30 min at 15,000rpm.  
9. Remove supernatant and measure volume 
10. Add 73g/Liter of ammonium sulfate to bring the ammonium sulfate from 30% to 
42.5%. 
11. After stirring 1 hour, centrifuge 30 min at 15,000 rpm in SS-34 rotor.  
12. Save supernatant for Tropomyosin  
a. Collect 65% ammonium sulfate fraction after adding 168 g ammonium 
sulfate per liter. Proceed to BvC Tropomyosin prep. 
13. Dialyze BvC Troponin against 20 mM MOPS pH 7, 50 mM NaCl, 1 mM DTT  
14. Equilibrate a Mono Q DEAE column with the same buffer 
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15.  Centrifuge 30 minutes at 40,000 rpm in a Ti 50.2 rotor to remove any precipitate. 
16. Load supernatant onto DEAE column and wash with two column of starting 
buffer.  
17. Run a ten column volume gradient to 1 M NaCl  
a. The cardiac troponin should elute in the middle of the gradient 
18. Check OD280-340 of fractions and run SDS-PAGE gel along with MW ladder to 




Preparation of Bovine Cardiac Tropomyosin from Ether Powder 
Adapted from: Potter (1982; volume 85 of methods in Enzymology) 
 
1. The 65% ammonium sulfate pellet from the BvC troponin protocol was brought 
up in minmal buffer and dialyzed extensively against the same buffer 
a. 1 M KCl, 2 mM MOPS, pH 7.2, 5 mM B-ME 
2. Equilibrate a hydroxylapatite column with 1 M KCl, 1 mM PO4, pH 7.2, 2 mM DTT 
3. The sample was spun at 30 minutes at 40,000 rpm in a Ti 50.2 rotor to clarify 
4. The sample was loaded onto the hydroxylapatite column 
5. The column was washed with two column volumes of equilibration buffer 
6. Elute protein with a five column volume gradient of phosphate to 250 mM 
a. Protein should elute near end of gradient 
7. Check OD280-340 and combine fractions with protein 
8. Carefully bring tropomyosin to pH 4.6 and allow to rest overnight on ice 
9. Centrifuge at 30,000 rpm for 40 minutes pour off supernatant 
10. Dissolve pellet in 4 mM MOPS, 40 mM KCl pH 7 or buffer of choice 




Recombinant Troponin C Preparation from 4 L TnI/TnC Culture 
Adapted from:  
Gafurov, B.; Chen, Y. D.; Chalovich, J. M. Biophys J 2004, 87 (3), 1825–1835. 
 
1) Prepare 2L 6 M Urea, 1 mM EDTA, 20 mM Tris/HCl, pH 8 (Soln. A) 
2) Prepare 1L Soln. A + 0.5 M NaCl 
3) Suspend pellet w/ about 40 mL Solution A + protease inhibitors 
a. Sigma 8465 cocktail. 43 mg dissolved in ~0.4 mL DMSO, ~1.6 mL water. 
b. Leupeptin to ~10 µM (~2.5 mg dissolved in ~1.0 mL water) 
c. Pepstatin to ~1 µM (~1.0 mg dissolved in ~1.0 mL DMSO) 
4) Sonicate 20 seconds x four times on ice 
5) Centrifuge at 19K for 1 hour at 4 C. TnI/TnC is in supernatant. 
6) Equilibrate DE52 (DEAE) column with cold solution A 
7) Add DTT and protease inhibitors 
a. DTT to 1 mM 
b. PMSF to 1mM. (17.4mg in 10 mL isopropanol for 10 mM stock. Store at -
20 C) 
c. Leupeptin and Pepstatin (as in step 3) 
8) Apply to DEAE column. 
a. TnI shouldn’t stick to column. Purify by troponin C affinity column. 
b. TnC should stick 
c. Elute troponin C with gradient to 0.5 M NaCl 
9) Gel to confirm troponin C. Combine fractions containing troponin C. 
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10) Dialyze versus Phenyl sepharose start buffer. 2-3 changes.  
a. 1 M NaCl, 1 mM CaCl2, 50 mM Tris pH 8 
11) Equilibrate Phenyl sepharose column w/ start buffer 
12) Apply sample to column.  
13) Wash column w/ 250 mL start buffer. 
14) Wash column w/ 250 mL 1 M NaCl, 0.2 mM CaCl2, 50 mM Tris pH 8 
15) Elute troponin C w/ 250 mL 5 mM EDTA, 20 mM Tris/HCl pH 8 
a. Wash further w/ buffer if no peak appears 
16) Run SDS-Page gel 
17) Dialyze versus experiment buffer or buffer containing at least 200 mM NaCl/KCl 
and 2 mM DTT 




Troponin I Purification using troponin C Affinity Column 
Adapted from: Pharmacia Fine Chemicals Affinity Chromatography principles and 
methods. Sweden, Ljungforetagen AB, Orebro, August 1983 
 
1. Dialyze clean Troponin C against coupling buffer 
a. 0.2 M NaHCO3, 0.5 M NaCl, pH 8.3 
2. Suspend freeze dried CnBr activated sepharose in ice cold 1 mM HCl 
a. 1 gram powder gives 3.5 mL gel volume. Use 5 mg protein per mL of gel 
3. Wash 15 minutes on sintered glass filter (porosity G3) using 200 mL 1 mM HCl 
per gram of dry powder in small aliquots. Final aliquot is sucked off until cracks 
appear in gel. 
4. Transfer gel immediately to troponin C solution using a gel to troponin C solution 
ratio of 1:2 
5. Allow to mix 2 hours end over end at room temperature 
6. Make 2 M ethanolamine pH solution that is equal in volume to the gel-TnC 
mixture 
7. Add 2 M ethanolamine solution to gel-TnC mixture to give ethanolamine 
concentration of 1 M 
8. Allow to mix end over end for 2 hours at room temperature 
9. Allow mixture to settle 
10. Suck off superanatant 
11. Wash alternately with coupling buffer and wash buffer three times each 
a. Wash buffer: 0.1 M acetate, 0.5 M NaCl, pH 4 
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12. Suspend in wash buffer and pour into clean, dry column 
13. Wash column with ten column volumes of wash buffer 
14. Dialyze impure Troponin I from DEAE column from TnC/TnI culture prep against 
6 M Urea, 0.1 mM CaCl2, 20 mM Tris/HCl, pH 8.0, 1 mM DTT 
15. Equilibrate troponin C affinity column with same buffer 
16. Load troponin I onto column and wash with two to four column volumes start 
buffer 
17. Collecting fractions equivalent to about half the loaded volume 
18. Elute with 6 M urea, 0.5 M NaCl, 1 mM EDTA, 20 mM Tris/HCl, pH 8.0, 1 mM 
DTT 




Recombinant troponin T Preparation from 4L Culture  
Adapted from:  
Gafurov, B.; Chen, Y. D.; Chalovich, J. M. Biophys J 2004, 87 (3), 1825–1835. 
 
1) Prepare 4L 6 M Urea, 1 mM EDTA, 20 mM Tris/HCl, pH 8 (Soln. A) 
2) Prepare 1L Soln. A + 0.5 M NaCl 
3) Suspend pellet w/ about 40 mL Solution A + protease inhibitors 
a. About 1.0 mg pepstatin dissolved in 0.1 mL DMSO 
b. About 2.5 mg leupeptin dissolved in ~1.0 mL water 
c. About 0.25 mg TPCK dissolved in 0.1 mL water 
d. About 0.25 mg TLCK dissolved in 0.1 mL water 
e. 43 mg sigma cocktail P8340 dissolved in 0.4 mL DMSO 
4) Sonicate 20 seconds x 6-8 times on ice 
5) Centrifuge at 19K for 1 hour at 4 degrees Celsius in Sorvall SS-34 rotor.  
6) Measure supernatant volume 
7) Add 176 g/L ammonium sulfate to 30% saturation. Let stir one hour at 4 degrees 
Celsius 
8) Centrifuge at 19,000 rpm for 30 minutes at 4 degrees Celsius in Sorvall SS-34 
rotor 
9) Measure supernatant volume 




11) Centrifuge at 19,000 rpm for 30 minutes at 4 degrees Celsius in Sorvall SS-34 
rotor 
12) Measure supernatant volume 
13) Add 110 g/L ammonium sulfate to 45% saturation. Let stir one hour at 4 degrees 
Celsius 
14) Centrifuge at 19,000 rpm for 30 minutes at 4 degrees Celsius in Sorvall SS-34 
rotor 
15) Save precipitate and suspend in about 30 mL solution A + protease inhibitors 
16) Dialyze versus 2 L of solution A 
17) Centrifuge at 19,000 rpm for 15 minutes to clarify 
18) Equilibrate Mono Q DEAE column with solution A 
19) Apply sample and wash with one column volume solution A 
20) Run 10 column volume gradient of solution A from 0.1 to 0.6 M NaCl 
21) Run 1 column volume gradient from 0.6 M NaCl to 1 M NaCl 
22) Continue washing with about 5 column volumes 1 M NaCl 
23) Check OD280-340 





Adapted from: Kobayashi, T. & Solaro, R. J. (2006) Increased Ca2+ Affinity of Cardiac 
Thin Filaments Reconstituted with Cardiomyopathy-related Mutant Cardiac Troponin I, 
Journal of Biological Chemistry. 281, 13471-13477. 
 
1. Dialyze each troponin subunit against 1 M NaCl, 5 mM MgCl2, 5 mM DTT, 20 mM 
MOPS pH 7 
2. Measure concentrations of each troponin subunit using Lowry assay 
3. Mix troponin T, troponin I and troponin C at a 1:1:1.05 molar ratio and dialyze 
against two changes of the same buffer with the addition of 6 M urea 
4. Dialyze against two changes of the same buffer without urea. 
5. Dialyze against same buffer as step 4 but with 0.3 M NaCl. 
6. Dialyze against same buffer as step 4 but with 0.1 M NaCl. 
7. Dialyze against 0.1 M NaCl, 5mM MgCl2, and 20 mM Tris/HCl, pH 8.0 
8. Centrifuge at 30,000 rpm for 40 minutes in a Ti 50.2 rotor  
9. Equilibrate a Mono Q DEAE column with 0.1 M NaCl, 5mM MgCl2, and 20 mM 
Tris/HCl, pH 8.0. 
10. Load troponin onto column and wash with two column volumes start buffer 




Modification of tropomyosin with the fluorescent probe acrylodan 
Adapted from: Ishii and Lehrer, Biochemistry 29 1160-1166, 1990 
 
1. Dialyze tropomyosin against reducing buffer:  
a. 100 mM KCl, 10 mM Pi buffer pH 6.5, 5 mM EDTA, 1 mM DTT.   
2. Add sufficient Pi buffer pH 6.0 to bring the final buffer concentration to 50 mM.  
3. Add DTT to 10 mM and incubate for at least 30 min. at 37oC. 
4. Dialyze the tropomyosin extensively against 3 mM MOPS, pH 7.5, 0.1 mM 
EDTA.   
5. Add guanidine HCl to the tropomyosin to make it 4 M  
6. Add a 5-fold excess of 6-Acryloyl-2-Dimethylaminonaphthalene and allow to 
react overnight at room temperature in the dark and with a nitrogen atmosphere. 
Remaining steps are done in dark. 
7. Stop the reaction by adding an excess of DTT.  
8. Centrifuge 30,000 rpm in a Ti 50 rotor for 20 min. Save the supernatant.  
9. Dialyze against at least 20-volumes 4M guanidine HCl, 3 mM MOPS, 0.1 mM 
EDTA. The dialysis should be changed 4 times at 8-12 hour intervals 




Modification of actin with the fluorescent probe pyrene 
Adapted from: Brenner & Korn (1983) JBC 258, 5013-5020 
 
1. Weigh out between 1.4 and 2 mg of pyrenyl iodoacetamide and add 
dimethylformamide to bring to fourteen mg/ml.  
2. Prepare Dilution Buffer:  
a. 100 mM Tris-HCl, pH 8.0, 1M KCl, 20 mM MgCl2, 1 mM CaCl2, 0.1% NaN3.  
3. Prepare Actin Buffer: 1 liter of actin buffer containing 4 mM imidazole, 2 mM 
MgCl2, 1 mM DTT. 
4. To 20 mg of F-actin in actin buffer (4mM imidazole, 2 mM MgCl2) add 1 ml of 
Dilution Buffer and water to 10 ml. 
a.  The water should be added to the dilution buffer prior to addition to actin. 
5. Stir in the dark until the actin is homogeneous. 
6. Add 0.1 ml of pyrenyl-iodoacetamide and incubate 12 hours at 20oC in the dark. 
7. Add a small flake of DTT to stop the reaction. 
8. Centrifuge the actin in a 50 Ti rotor for 20 min at 30,000 rpm.  
9. Save the supernatant containing the pyrenyl actin. 
a. The pellet is unreacted pyrenyliodoacetamide. 
10. Centrifuge the supernatant in the 50Ti rotor at 45,000 rpm for 1h.  
11. Discard the supernatant.  
12. Add 5 ml of actin buffer to the pellet and allow to stand on ice in the dark for 1hr 
13. Homogenize the pellet and dialyze overnight in 500 ml of actin buffer with out DTT.  
14. Determine the concentration of actin as described in the Actin prep. 
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Protein Detection and Concentration Measure Using Spectrophotometer 
1. Set spectrophotometer to measure absorbance at 280 nm and to subtract out 
absorbance at 340 nm 
2. Add protein buffer to each 1 cm path length cell and correct baseline  
3. Add protein to cell and collect A280-340 
Concentration (mg/mL) = ABS/Extinction Coefficient 
Concentration (uM) = mg/mL x E6 / MW 
Protein Molecular Weight, MW (grams/mol) Extinction Coefficient  
Myosin S-1 120,000 0.75 
Actin* 42,000 1.15* 
Myosin 480,000 0.56 
BSA 64,000 0.66  
HC Troponin T 35,923 0.504 
HC Troponin I 24,000 0.397 
HC Troponin C 18,400 0.214 
Troponin 71,000 0.37 





Adapted from: O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, J. Biol. 
Chem. 193, 265 (1951). 
 
1. Bring 1-20 µg protein to 0.2 mL with water in a 1.5 mL Eppendorf tube 
a. Make 3 solutions of different concentrations for each protein to be 
measured as well as 3 solutions of a standard protein (such as BSA) of 
known concentration. Also make one blank solution with no protein. 
2. Add 0.2 mL reagent A to each solution 
a. 1 part CTC, 1 part 0.8 M NaOH, 2 parts 5% SDS 
i. CTC: 0.1% w/v CuSO4*5 H2O, 0.2% w/v sodium/potassium tartrate, 
10% w/v Na2CO3 
3. Vortex and let stand 10 minutes 
4. Add 0.1 mL reagent B 
a. 1 part 2 N Folin reagent, 5 parts water 
5. Vortex and let stand 30 minutes 
6. Turn on spectrophotometer and set wavelength to 680nm 
7. Zero baseline using blank 
8. Measure absorbance at 680 nm for each solution 
9. Plot each protein absorbance versus the volume of protein added 
10. Calculate the slope of each  




∗ [BSA]  
164 
 
Pouring polyacrylamide gel 
 
1) Assemble gel cartridge 
2) For two 12% gels add the following to a 15 mL conical tube 
a. 3.2 mL sterile H2O 
b. 4 mL Acrylamide/Bis-acrylamide (30%/0.8% w/v) 
c. 2.6 mL 1.5 M Tris pH 8.8 
d. 0.1 mL 10% SDS 
e. 0.1 mL 10% ammonium persulfate (added immediately before pouring) 
f. 0.010 mL Temed (added immediately before pouring) 
3) Quickly close and invert conical. Use disposable pipet to transfer solution to the 
cartridge. Leave about 2 cm of space from the top. 
4) Add solid butanol above solution 
5) Allow to sit at least thirty minutes but no longer than 2 hours at room temperature 
6) For two stacking gels add the following to a 15 mL conical tube 
a. 3 mL sterile H2O 
b. 0.67 mL Acrylamide/Bis-acrylamide (30%/0.8% w/v) 
c. 1.25 mL 0.5 M Tris pH 6.8 
d. 0.05 mL 10% SDS 
e. 0.05 mL 10% ammonium persulfate (added immediately before pouring) 
f. 0.005 mL Temed (added immediately before pouring) 
7) Quickly close and invert conical. Use disposable pipet to transfer solution to the 
cartridge. Fill nearly to top. 
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8) Place loading spacer into cartridge immediately 
9) Allow to sit at least thirty minutes 




Preparing Samples and Running SDS-PAGE gel 
 
1. Add 30 µL of each protein to 1.5 mL Eppendorf tubes 
a. If protein is close to or greater than 10 mg/mL, use less than 30 µL and 
bring up to 30 µL with buffer or water 
2. Add 7 µL of 5X loading buffer to each 
a. 10% SDS, 10 mM DTT, 20% w/v glycerol, 0.2 M Tris-HCl pH 6.8 
3. Boil each tube 5 minutes 
4. Transfer poured and polymerized polyacrylamide gel to running apparatus 
5. Fill apparatus with Laemmli buffer 
a. 0.2 M glycine, 0.01 M Tris Base, 0.035 mM SDS 
6. Load between 5 and 20 uL protein solutions 
7. Connect apparatus to voltage source 
8. Run at 75 volts until sample is past the stacking gel. Can then turn voltage up to 
150 volts if desired. 
9. Turn off voltage source once front nears bottom of gel 
10. Remove gel cartridge and carefully transfer gel to small container 
11. If using coomassie stain, cover the gel with the coomassie solution. 
a. 10% acetic acid, 30% methanol, 0.01% coomassie 
12. Optional: Cover loosely with lid and microwave 30 seconds 
13. Allow to mix overnight on rocker (or ten minutes if microwaved) 
14. Pour off coomassie stain solution 




Obtaining and Analyzing FRET Data 
1) After turning on all equipment (ie. Fluorometer, water bath), open FluorEssence 
software 
 
2) Click the red “M” in toolbar. After initialization, click emission. 
3) If you already have a blank file, proceed to step 8. A blank file must be created to 
subtract from your experiments under the same condition. The blank solution 
should be identical to your experiment solution but in the absence of fluorescent 
probes. To create a blank file, enter the parameters as in the image below but 
DO NOT click the checkbox for “Blank Subtraction” (Note these are the 
parameters used for the IAEDANS-DABMI FRET pair. Different probes may 
require different values). Use the tabs on the left side of the window to switch 





4) Load Blank solution into Cell. Click Run and wait for data collection to finish 





6) Click the “…” button to the right of export graph 
 
7) Find the plot you wish to save as your baseline. The baseline should be the S1c 
plot NOT the S1c/R1c plot. Move it into the right column by clicking the “>>” 
button. Note that the blank file will be created from the plot in position one if there 
are multiple plots in the file. Click OK. Save the file where you can locate it 
shortly. 
8) Load your experiment solution into the cleaned cell.  
170 
 
9) Click the button to the right of the red “M”. This opens your most recently used 
parameter settings. Fill in the same parameter settings as in step 3 but this time, 
check the “Blank Subtraction” box. This will prompt you to locate your blank 
subtraction file.  
10) After loading your blank subtraction file and verifying all parameters are correct, 
click Run 
11) Wait for data acquisition completion.  
12) Once complete, use the tabs at the bottom of the following window to cycle 
between the different data and plots obtained. 
 




14) We want to create a text file for each set of wavelengths and CPS/microamps 
values. Copy the data by highlighting and pasting into a new text file. A separate 
text file should be created for each experiment (ie. With and without acceptor 
present). Save that file in a location that can be easily located. 
 
15) Open FITYK software. Click data>quick load file. Locate the text file for one of 
your experiments just generated. Your data points should appear upon opening. 




16) Click on the minimum point of the plot. In most cases with this FRET pair, this will 
be at approximately 410 nm. Click GUI>Baseline handling>Subtract Baseline 
17) Click the “Add new peak” button circled in red below FOUR times (three times if 
there is no appreciable peak around 380 nm). On the right side of the window, 
note the “functions” tab. Each peak has a Gaussian fit with different parameters 
that can be modified at the bottom right of the window. One peak should be 
automatically assigned at approximately 380 nm. Modify the parameters as 
follows: 
 
380 nm Peak: Lock all automatically assigned values by clicking the lock icon 
500 peak:  
 Height: 10,000 
 Center: 500, Lock 
 Hwhm; 40 
550 peak:  
 Height: 10,000 
 Center: 550, Lock 
 Hwhm; 40 
700 peak:  
Height: 10,000, Lock 
 Center: 700, Lock 






18) Click fit>Run>Ok 
19) Unlock the height parameter on the 700 nm peak. Manually adjust to achieve 
best fit to data. Re-lock the height value. 
20) Unlock all parameters on the 500 nm and 550 nm peak 
21) Click fit> Run>OK 




23) For the two peaks corresponding to the main ~492 nm peak of interest, on the 
right-hand side of the window, add the Area value for each (circled in red above). 
This is the integrated fluorescence intensity value 
 
24) Once the integrated values have been obtained for the absence and presence of 
acceptor probe. Calculate the FRET efficiency: 
 
Efficiency= (1-(DA/D))*(1/labelling percentage) 
25) Open Fluortools AE software. Click the circled red button as shown in the image 
below to load the Absorption spectra of the acceptor probe (DABMI tropomyosin 
in this case) and the emission spectra of the donor (IAEDANS troponin in this 
case). Note the emission spectra is that obtained in the experiment with all other 





26) The Absorption spectra should be normalized to the extinction coefficient of the 
probe (For DABMI 24,800 M-1cm-1 at 460 nm). For DABMI, this is done by 
clicking the calculator and multiplying by a factor that makes the absorbance at 
460 nm equal 24,800. 
27) The emission spectra should be normalized at the emission peak. For IAEDANS, 
this is 492 nm. Click Tools>Normalize Spectra>Normalize Spectra (at 
wavelength). Click the Em spectra in the following window then OK. Type 492 nm 
(IAEDANS), then click OK. 
28) Now we can calculate the overlap integral. Click the Button circled in red below. 
An overlap integral value will be shown in the textbox at the bottom of the 




29) Open Wolfram Mathematica and enter the following program. Change the values 
of the quantum yield (qd), orientation factor (k2), refractive index (nn), overlap 












30) This program outputs a value of the R0 (labelled ro) and the Distance in 
Angstroms. The distance calculation produces multiple values. Only one is not 
imaginary. Record that value as the distance. 
 
Appendix C: Supplementary Data 
Fluorescent Probe Structures 
 




ATPchase of WT, 275C and ∆14 troponin T 
 
Figure 39: Formation of the inactive B state seen by acrylodan-tropomyosin 
fluorescence.Time courses of acrylodan fluorescence changes for actin regulated by 
wild type (1), 275C (2) and ∆14 troponin T (3) following the rapid detachment of myosin 
S1 in the absence of Ca2+ at 10 °C. Traces shown are averages of at least five different 
measurements. 2 µM actin, 0.43 µM tropomyosin, 0.43 µM troponin and 2 µM S1 in 20 
mM MOPS, 152 mM KCl, 4 mM MgCl2, 1 mM dithiothreitol and 2 mM EGTA was rapidly 
mixed with 2 mM ATP, 20 mM MOPS, 152 mM KCl, 8 mM MgCl2, 1 mM dithiothreitol 
and 2 mM EGTA. Acrylodan was excited via a monochromator at 391 nm and observed 




Representative ATPase data 
 
Figure 40: Representative ATPase data at saturating calcium. Regulated actin (squares, 
A), Unregulated Actin (Circles, B), Actin-tropomyosin (Triangles, C). Measurements 
were made at 25o C and pH 7.0 in solutions containing 1 mM ATP, 3 mM MgCl2, 34 mM 
KCl, 10 mM MOPS, 1 mM dithiothreitol and 0.1 mM CaCl2. The concentrations of S1, 





Arrhenius Plot of efficiency of transfer between IAEDANS 289C troponin T and 
C190 of tropomyosin 
 
Figure 41 Arrhenius plot of rate of efficiency change between IAEDANS 289C TnT and 
DABMI fluorescence acceptor probe on C190 of tropomyosin following the rapid 
detachment of myosin S1 from actin at very low Ca2+ concentrations at different 
temperatures. 2 µM actin, 0.51 µM tropomyosin, 0.43 µM troponin and 2 µM S1 in 20 
mM MOPS, 152 mM KCl, 4 mM MgCl2, 1 mM dithiothreitol and 2 mM EGTA was rapidly 
mixed with 2 mM ATP, 20 mM MOPS, 152 mM KCl, 8 mM MgCl2, 1 mM dithiothreitol 
and 2 mM EGTA at 25° C. IAEDANS was excited using a 340nm LED and the 
fluorescence monitored through a 435/451/460 filter. Apparent rates: G, 7.0(±0.1); H, 




In-gel digestion and mass spectrometric analysis of wild type, 289C, and HAHA 
289C troponin T constructs 
1) An SDS-PAGE Gel was run 
at different concentrations for 
each troponin T construct. 
Lane 1 is a MW standard. 
Lanes 3-5 are wildtype 
troponin T. Lanes 7-9 are 
289C troponin T. 
 
2) A standard protocol was performed for the chymotrypsin in-gel digestion. See: 
Shevchenko, A., Tomas, H., Havli, J., Olsen, J. V, and Mann, M. (2007) In-gel 
digestion for mass spectrometric characterization of proteins and proteomes. 
Nat. Protoc. 1, 2856. 
3) Liquid chromatography mass spectrometric analysis was performed by Dr. 
Kimberly Kew. The results for HAHA troponin T are shown below. The sequence 
of the HAHA 289C troponin T C-terminal residues 251-289 are shown along the 
top. The colored bars indicate different chymotryptic digest fragments with 
molecular weights that could be attributed to the molecular weight of sections of 
the defined sequence. The numbers on the colored bars indicate the time at 
which the fragment eluted from liquid chromatography. Three fragments were 
identified that corresponded with the C-terminus of HAHA troponin T where the 
basic residues were replaced with alanine. This verified that we had successfully 





Preparation of Calcium-EGTA buffer 
1) 10 grams of calcium chloride and EGTA were weighed into glass beakers 
2) The beakers were placed into an over at 170° F overnight to drive off water. 
3) Calcium and EGTA were accurately weighed to make a solution that is 100 mM 
of each.  
4) Each was added to a beaker and the volume brought near the total final volume. 
5) The solution was brought to pH 7 with NaOH. 
6) The solution was added to a volumetric flask and brought to volume.  
7) The table below (Table 12) shows the concentration of Calcium-EGTA buffer, 
calcium, and EGTA that were used to achieve the desired pCa.  
a. These values were calculated using Maxchelator: 
https://somapp.ucdmc.ucdavis.edu/pharmacology/bers/maxchelator/downloads.htm 
b.  
Table 12: Ca2+-EGTA buffer, Ca2+ and EGTA used to reach desired pCa 
Ca2+-EGTA (mM) Calcium (mM) EGTA (mM) Free Calcium (mM) pCa 
4 0 3 6.29E-07 6.20 
4 0 0.5 3.70E-06 5.43 
4 0 0.1 1.62E-05 4.79 
2 0 0 3.05E-05 4.52 
8 0 0 6.15E-05 4.21 
4 0.2 0 2.09E-04 3.68 
4 0.5 0 5.04E-04 3.30 





SDS-PAGE gel of actin-∆16 peptide spin down assay 
 
Figure 42: SDS-PAGE gel of actin-∆16 peptide spin down assay. The major band 




FRET Titration of DABMI tropomyosin 
 
Figure 43: Efficiency of FRET between IAEDANS 289C troponin T and DABMI C190 
tropomyosin at different DABMI tropomyosin concentrations. 2 µM actin, 0.29 µM 
troponin in 20 mM MOPS, 152 mM KCl, 4 mM MgCl2, 1 mM dithiothreitol and 2 mM 
EGTA. IAEDANS was excited at 336 nm. FRET efficiency determined as described in 
Chapter 2: Experimental Methods. 
 
 
